Till sidinnehåll
Kunskapsbank för cancervården Till cancercentrum.se


Abdel-Misih, S. R., Hatzaras, I., Schmidt, C., Saab, T. B., Klemanski, D., Muscarella, P., Melvin, W. S., Ellison, E. C., & Bloomston, M. (2011). Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease. Ann Surg Oncol, 18(4), 1116-1121. https://doi.org/10.1245/s10434-010-1397-1

Abe, T., Ohuchida, K., Miyasaka, Y., Ohtsuka, T., Oda, Y., & Nakamura, M. (2016). Comparison of Surgical Outcomes Between Radical Antegrade Modular Pancreatosplenectomy (RAMPS) and Standard Retrograde Pancreatosplenectomy (SPRS) for Left-Sided Pancreatic Cancer. World J Surg, 40(9), 2267-2275. https://doi.org/10.1007/s00268-016-3526-x

Abrams, R. A., Lowy, A. M., O'Reilly, E. M., Wolff, R. A., Picozzi, V. J., & Pisters, P. W. (2009). Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol, 16(7), 1751-1756. https://doi.org/10.1245/s10434-009-0413-9

Abramson, M. A., Swanson, E. W., & Whang, E. E. (2009). Surgical resection versus palliative chemoradiotherapy for the management of pancreatic cancer with local venous invasion: a decision analysis. J Gastrointest Surg, 13(1), 26-34. https://doi.org/10.1007/s11605-008-0648-y

Adiamah, A., Arif, Z., Berti, F., Singh, S., Laskar, N., & Gomez, D. (2019). The Use of  Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials. World J Surg, 43(7), 1788-1801. https://doi.org/10.1007/s00268-019-04956-6

Aggarwal, G., Kamada, P., & Chari, S. T. (2013). Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers. Pancreas, 42(2), 198-201. https://doi.org/10.1097/MPA.0b013e3182592c96

Ahmed Ali, U., Jens, S., Busch, O. R., Keus, F., van Goor, H., Gooszen, H. G., & Boermeester, M. A. (2014). Antioxidants for pain in chronic pancreatitis. Cochrane Database Syst Rev(8), CD008945. https://doi.org/10.1002/14651858.CD008945.pub2

Al-Hawary, M. M., Francis, I. R., Chari, S. T., Fishman, E. K., Hough, D. M., Lu, D. S., Macari, M., Megibow, A. J., Miller, F. H., Mortele, K. J., Merchant, N. B., Minter, R. M., Tamm, E. P., Sahani, D. V., & Simeone, D. M. (2014). Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology, 270(1), 248-260. https://doi.org/10.1148/radiol.13131184

Alanazi, A. A. (2014). Reducing anxiety in preoperative patients: a systematic review. British Journal of Nursing, 23(7), 387-393.

Allen, P. J., Gönen, M., Brennan, M. F., Bucknor, A. A., Robinson, L. M., Pappas, M. M., Carlucci, K. E., D'Angelica, M. I., DeMatteo, R. P., Kingham, T. P., Fong, Y., & Jarnagin, W. R. (2014). Pasireotide for postoperative pancreatic fistula. N Engl J Med, 370(21), 2014-2022. https://doi.org/10.1056/NEJMoa1313688

Almadi, M. A., Barkun, A. N., & Martel, M. (2013). No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis. Clin Gastroenterol Hepatol, 11(1), 27-37 e21. https://doi.org/10.1016/j.cgh.2012.10.019

Andren-Sandberg, A., Wagner, M., Tihanyi, T., Lofgren, P., & Friess, H. (1999). Technical aspects of left-sided pancreatic resection for cancer. Dig Surg, 16(4), 305-312. https://doi.org/18740

Ansorge, C., Strommer, L., Andren-Sandberg, A., Lundell, L., Herrington, M. K., & Segersvard, R. (2012). Structured intraoperative assessment of pancreatic gland characteristics in predicting complications after pancreaticoduodenectomy. Br J Surg, 99(8), 1076-1082. https://doi.org/10.1002/bjs.8784

Appelby. (1953). The coeliac axis in the expansion of the operation for gastric carcinoma. Cancer, 6(4), 704-707.

Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hutterer, E., Isenring, E., Kaasa, S., Krznaric, Z., Laird, B., Larsson, M., Laviano, A., Muhlebach, S., Muscaritoli, M., Oldervoll, L., Ravasco, P., Solheim, T., Strasser, F., de van der Schueren, M., & Preiser, J. C. (2016). ESPEN guidelines on nutrition in cancer patients. Clin Nutr. https://doi.org/10.1016/j.clnu.2016.07.015

Arnelo, U., Siiki, A., Swahn, F., Segersvard, R., Enochsson, L., del Chiaro, M., Lundell, L., Verbeke, C. S., & Lohr, J. M. (2014). Single-operator pancreatoscopy is helpful in the evaluation of suspected intraductal papillary mucinous neoplasms (IPMN). Pancreatology, 14(6), 510-514. https://doi.org/10.1016/j.pan.2014.08.007

Arnelo, U., Siiki, A., Swahn, F., Segersvärd, R., Enochsson, L., del Chiaro, M., Lundell, L., Verbeke, C. S., & Löhr, J. M. (2014). Single-operator pancreatoscopy is helpful in the evaluation of suspected intraductal papillary mucinous neoplasms (IPMN). Pancreatology, 14(6), 510-514. https://doi.org/10.1016/j.pan.2014.08.007

Asbun, H. J., Moekotte, A. L., Vissers, F. L., Kunzler, F., Cipriani, F., Alseidi, A., D'Angelica, M. I., Balduzzi, A., Bassi, C., Björnsson, B., Boggi, U., Callery, M. P., Del Chiaro, M., Coimbra, F. J., Conrad, C., Cook, A., Coppola, A., Dervenis, C., Dokmak, S., Edil, B. H., Edwin, B., Giulianotti, P. C., Han, H. S., Hansen, P. D., van der Heijde, N., van Hilst, J., Hester, C. A., Hogg, M. E., Jarufe, N., Jeyarajah, D. R., Keck, T., Kim, S. C., Khatkov, I. E., Kokudo, N., Kooby, D. A., Korrel, M., de Leon, F. J., Lluis, N., Lof, S., Machado, M. A., Demartines, N., Martinie, J. B., Merchant, N. B., Molenaar, I. Q., Moravek, C., Mou, Y. P., Nakamura, M., Nealon, W. H., Palanivelu, C., Pessaux, P., Pitt, H. A., Polanco, P. M., Primrose, J. N., Rawashdeh, A., Sanford, D. E., Senthilnathan, P., Shrikhande, S. V., Stauffer, J. A., Takaori, K., Talamonti, M. S., Tang, C. N., Vollmer, C. M., Wakabayashi, G., Walsh, R. M., Wang, S. E., Zinner, M. J., Wolfgang, C. L., Zureikat, A. H., Zwart, M. J., Conlon, K. C., Kendrick, M. L., Zeh, H. J., Hilal, M. A., & Besselink, M. G. (2020). The Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection. Ann Surg, 271(1), 1-14. https://doi.org/10.1097/sla.0000000000003590

Assifi, M. M., Lu, X., Eibl, G., Reber, H. A., Li, G., & Hines, O. J. (2011). Neoadjuvant therapy in pancreatic adenocarcinoma: a meta-analysis of phase II trials. Surgery, 150(3), 466-473. https://doi.org/10.1016/j.surg.2011.07.006

Bachellier, P., Addeo, P., Faitot, F., Nappo, G., & Dufour, P. (2020). Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?: A Single Institution's Experience With 118 Patients. Ann Surg, 271(5), 932-940. https://doi.org/10.1097/sla.0000000000003010

Bachmann, J., Ketterer, K., Marsch, C., Fechtner, K., Krakowski-Roosen, H., Buchler, M. W., Friess, H., & Martignoni, M. E. (2009). Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function. BMC Cancer, 9, 255. https://doi.org/10.1186/1471-2407-9-255

Bakkevold, K. E., Arnesjo, B., & Kambestad, B. (1992). Carcinoma of the pancreas and papilla of Vater: presenting symptoms, signs, and diagnosis related to stage and tumour site. A prospective multicentre trial in 472 patients. Norwegian Pancreatic Cancer Trial. Scand J Gastroenterol, 27(4), 317-325. http://www.ncbi.nlm.nih.gov/pubmed/1589710

Baldwin, C., & Weekes, C. E. (2012). Dietary counselling with or without oral nutritional supplements in the management of malnourished patients: a systematic review and meta-analysis of randomised controlled trials. J Hum Nutr Diet, 25(5), 411-426. https://doi.org/10.1111/j.1365-277X.2012.01264.x

Barkun, A. N., Adam, V., Martel, M., AlNaamani, K., & Moses, P. L. (2015). Partially covered self-expandable metal stents versus polyethylene stents for malignant biliary obstruction: a cost-effectiveness analysis. Can J Gastroenterol Hepatol, 29(7), 377-383. http://www.ncbi.nlm.nih.gov/pubmed/26125107

Barnes, E. A., & Bruera, E. (2002). Fatigue in patients with advanced cancer: a review. Int J Gynecol Cancer, 12(5), 424-428. http://www.ncbi.nlm.nih.gov/pubmed/12366656

Barone, E., Corrado, A., Gemignani, F., & Landi, S. (2016). Environmental risk factors for pancreatic cancer: an update. Arch Toxicol, 90(11), 2617-2642. https://doi.org/10.1007/s00204-016-1821-9

Bartlett, E. K., Wachtel, H., Fraker, D. L., Vollmer, C. M., Drebin, J. A., Kelz, R. R., Karakousis, G. C., & Roses, R. E. (2014). Surgical palliation for pancreatic malignancy: practice patterns and predictors of morbidity and mortality. J Gastrointest Surg, 18(7), 1292-1298. https://doi.org/10.1007/s11605-014-2502-8

Beane, J. D., House, M. G., Pitt, S. C., Kilbane, E. M., Hall, B. L., Parmar, A. D., Riall, T. S., & Pitt, H. A. (2015). Distal pancreatectomy with celiac axis resection: what are the added risks? HPB (Oxford), 17(9), 777-784. https://doi.org/10.1111/hpb.12453

Beigelman-Aubry, C., Hill, C., & Grenier, P. A. (2007). Management of an incidentally discovered pulmonary nodule. Eur Radiol, 17(2), 449-466. https://doi.org/10.1007/s00330-006-0399-7

Belyaev, O., Seelig, M. H., Muller, C. A., Tannapfel, A., Schmidt, W. E., & Uhl, W. (2008). Intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol, 42(3), 284-294. https://doi.org/10.1097/MCG.0b013e3180500761

Ben, Q., Xu, M., Ning, X., Liu, J., Hong, S., Huang, W., Zhang, H., & Li, Z. (2011). Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer, 47(13), 1928-1937. https://doi.org/10.1016/j.ejca.2011.03.003

Benini, L., Amodio, A., Campagnola, P., Agugiaro, F., Cristofori, C., Micciolo, R., Magro, A., Gabbrielli, A., Cabrini, G., Moser, L., Massella, A., Vantini, I., & Frulloni, L. (2013). Fecal elastase-1 is useful in the detection of steatorrhea in patients with pancreatic diseases but not after pancreatic resection. Pancreatology, 13(1), 38-42. https://doi.org/10.1016/j.pan.2012.11.307

Berrington de Gonzalez, A., Sweetland, S., & Spencer, E. (2003). A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer, 89(3), 519-523. https://doi.org/10.1038/sj.bjc.6601140

Bhardwaj, N., Dennison, A. R., Maddern, G. J., & Garcea, G. (2016). Management implications of resection margin histology in patients undergoing resection for IPMN: A meta-analysis. Pancreatology, 16(3), 309-317. https://doi.org/10.1016/j.pan.2016.02.008

Billings, B. J., Christein, J. D., Harmsen, W. S., Harrington, J. R., Chari, S. T., Que, F. G., Farnell, M. B., Nagorney, D. M., & Sarr, M. G. (2005). Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up? J Gastrointest Surg, 9(8), 1059-1066; discussion 1066-1057. https://doi.org/10.1016/j.gassur.2005.05.014

Bipat, S., Phoa, S. S., van Delden, O. M., Bossuyt, P. M., Gouma, D. J., Lameris, J. S., & Stoker, J. (2005). Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr, 29(4), 438-445. http://www.ncbi.nlm.nih.gov/pubmed/16012297

Birkmeyer, J. D., Siewers, A. E., Finlayson, E. V., Stukel, T. A., Lucas, F. L., Batista, I., Welch, H. G., & Wennberg, D. E. (2002). Hospital volume and surgical mortality in the United States. N Engl J Med, 346(15), 1128-1137. https://doi.org/10.1056/NEJMsa012337

Birkmeyer, J. D., Stukel, T. A., Siewers, A. E., Goodney, P. P., Wennberg, D. E., & Lucas, F. L. (2003). Surgeon volume and operative mortality in the United States. N Engl J Med, 349(22), 2117-2127. https://doi.org/10.1056/NEJMsa035205

Birkmeyer, J. D., Sun, Y., Wong, S. L., & Stukel, T. A. (2007). Hospital volume and late survival after cancer surgery. Ann Surg, 245(5), 777-783. https://doi.org/10.1097/01.sla.0000252402.33814.dd

Birkmeyer, N. J., Goodney, P. P., Stukel, T. A., Hillner, B. E., & Birkmeyer, J. D. (2005). Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer, 103(3), 435-441. https://doi.org/10.1002/cncr.20785

Boggi, U., Del Chiaro, M., Croce, C., Vistoli, F., Signori, S., Moretto, C., Amorese, G., Mazzeo, S., Cappelli, C., Campani, D., & Mosca, F. (2009). Prognostic implications of tumor invasion or adhesion to peripancreatic vessels in resected pancreatic cancer. Surgery, 146(5), 869-881. https://doi.org/10.1016/j.surg.2009.04.029

Boulay, B. R., Gardner, T. B., & Gordon, S. R. (2010). Occlusion rate and complications of plastic biliary stent placement in patients undergoing neoadjuvant chemoradiotherapy for pancreatic cancer with malignant biliary obstruction. J Clin Gastroenterol, 44(6), 452-455. https://doi.org/10.1097/MCG.0b013e3181d2ef06

Bradley, K. A., Rubinsky, A. D., Sun, H., Bryson, C. L., Bishop, M. J., Blough, D. K., Henderson, W. G., Maynard, C., Hawn, M. T., Tonnesen, H., Hughes, G., Beste, L. A., Harris, A. H., Hawkins, E. J., Houston, T. K., & Kivlahan, D. R. (2011). Alcohol screening and risk of postoperative complications in male VA patients undergoing major non-cardiac surgery. J Gen Intern Med, 26(2), 162-169. https://doi.org/10.1007/s11606-010-1475-x

Brierley, J., Gospodarowicz, M. K., & Wittekind, C. (2017). TNM classification of malignant tumours. John Wiley & Sons, Inc.

Briggs, C. D., Irving, G. R., Cresswell, A., Peck, R., Lee, F., Peterson, M., & Cameron, I. C. (2010). Percutaneous transhepatic insertion of self-expanding short metal stents for biliary obstruction before resection of pancreatic or duodenal malignancy proves to be safe and effective. Surg Endosc, 24(3), 567-571. https://doi.org/10.1007/s00464-009-0598-9

Brook, O. R., Brook, A., Vollmer, C. M., Kent, T. S., Sanchez, N., & Pedrosa, I. (2015). Structured reporting of multiphasic CT for pancreatic cancer: potential effect on staging and surgical planning. Radiology, 274(2), 464-472. https://doi.org/10.1148/radiol.14140206

Bruera, E., & Sweeney, C. (2002). Methadone use in cancer patients with pain: a review. J Palliat Med, 5(1), 127-138. https://doi.org/10.1089/10966210252785097

Brune, K. A., Lau, B., Palmisano, E., Canto, M., Goggins, M. G., Hruban, R. H., & Klein, A. P. (2010). Importance of age of onset in pancreatic cancer kindreds. J Natl Cancer Inst, 102(2), 119-126. https://doi.org/10.1093/jnci/djp466

Bruno, M. J., Haverkort, E. B., Tijssen, G. P., Tytgat, G. N., & van Leeuwen, D. J. (1998). Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Gut, 42(1), 92-96. http://www.ncbi.nlm.nih.gov/pubmed/9505892

Buc, E., Flamein, R., Golffier, C., Dubois, A., Nagarajan, G., Futier, E., & Pezet, D. (2010). Peng's binding pancreaticojejunostomy after pancreaticoduodenectomy: a French prospective study. J Gastrointest Surg, 14(4), 705-710. https://doi.org/10.1007/s11605-009-1125-y

Bunger, S., Laubert, T., Roblick, U. J., & Habermann, J. K. (2011). Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview. J Cancer Res Clin Oncol, 137(3), 375-389. https://doi.org/10.1007/s00432-010-0965-x

Burdelski, C. M., Reeh, M., Bogoevski, D., Gebauer, F., Tachezy, M., Vashist, Y. K., Cataldegirmen, G., Yekebas, E., Izbicki, J. R., & Bockhorn, M. (2011). Multivisceral resections in pancreatic cancer: identification of risk factors. World J Surg, 35(12), 2756-2763. https://doi.org/10.1007/s00268-011-1263-8

Burrell, S. A., Yeo, T. P., Smeltzer, S. C., Leiby, B. E., Lavu, H., Kennedy, E. P., & Yeo, C. J. (2018). Symptom clusters in patients with pancreatic cancer undergoing surgical resection: part I. Oncology Nursing Forum,

Burris, H. A., 3rd, Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., Nelson, R., Dorr, F. A., Stephens, C. D., & Von Hoff, D. D. (1997). Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol, 15(6), 2403-2413. https://doi.org/10.1200/jco.1997.15.6.2403

Callery, M. P., Chang, K. J., Fishman, E. K., Talamonti, M. S., William Traverso, L., & Linehan, D. C. (2009). Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol, 16(7), 1727-1733. https://doi.org/10.1245/s10434-009-0408-6

Campbell, V. ( 2013). Pathology of the Pancreas, Springer, .

Cao, Y., Gu, H.-Y., Huang, Z.-D., Wu, Y.-P., Zhang, Q., Luo, J., Zhang, C., & Fu, Y. (2019). Impact of Enhanced Recovery after Surgery on Postoperative Recovery for Pancreaticoduodenectomy: Pooled analysis of Observational Study. Frontiers in oncology, 9, 687.

Capurso, G., Signoretti, M., Valente, R., Arnelo, U., Lohr, M., Poley, J. W., Delle Fave, G., & Del Chiaro, M. (2015). Methods and outcomes of screening for pancreatic adenocarcinoma in high-risk individuals. World J Gastrointest Endosc, 7(9), 833-842. https://doi.org/10.4253/wjge.v7.i9.833

Casadei, R., Ricci, C., Silvestri, S., Campra, D., Ercolani, G., D'Ambra, M., Pinna, A. D., Fronda, G. R., & Minni, F. (2013). Peng's binding pancreaticojejunostomy after pancreaticoduodenectomy. An Italian, prospective, dual-institution study. Pancreatology, 13(3), 305-309. https://doi.org/10.1016/j.pan.2013.03.003

Cavazzoni, E., Bugiantella, W., Graziosi, L., Franceschini, M. S., & Donini, A. (2013). Malignant ascites: pathophysiology and treatment. Int J Clin Oncol, 18(1), 1-9. https://doi.org/10.1007/s10147-012-0396-6

Cecka, F., Lovecek, M., Jon, B., Skalicky, P., Subrt, Z., Neoral, C., & Ferko, A. (2015). Intra-abdominal drainage following pancreatic resection: A systematic review. World J Gastroenterol, 21(40), 11458-11468. https://doi.org/10.3748/wjg.v21.i40.11458

Chandrashekhara, S. H., Gamanagatti, S., Singh, A., & Bhatnagar, S. (2016). Current Status of Percutaneous Transhepatic Biliary Drainage in Palliation of Malignant Obstructive Jaundice: A Review. Indian J Palliat Care, 22(4), 378-387. https://doi.org/10.4103/0973-1075.191746

Cheng, Y., Ye, M., Xiong, X., Peng, S., Wu, H. M., Cheng, N., & Gong, J. (2016). Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery. Cochrane Database Syst Rev, 2, CD009621. https://doi.org/10.1002/14651858.CD009621.pub2

Chong, A., Venugopal, K., Segarajasingam, D., & Lisewski, D. (2011). Tumor seeding after EUS-guided FNA of pancreatic tail neoplasia. Gastrointest Endosc, 74(4), 933-935. https://doi.org/10.1016/j.gie.2010.10.020

Chua, T. C., de Reuver, P. R., Staerkle, R. F., Neale, M. L., Arena, J., Mittal, A., Shanbhag, S. T., Gill, A. J., & Samra, J. S. (2016). Transverse closure of mesenterico-portal vein after vein resection in pancreatoduodenectomy. Eur J Surg Oncol, 42(2), 211-218. https://doi.org/10.1016/j.ejso.2015.08.167

Claudon, M., Dietrich, C. F., Choi, B. I., Cosgrove, D. O., Kudo, M., Nolsoe, C. P., Piscaglia, F., Wilson, S. R., Barr, R. G., Chammas, M. C., Chaubal, N. G., Chen, M. H., Clevert, D. A., Correas, J. M., Ding, H., Forsberg, F., Fowlkes, J. B., Gibson, R. N., Goldberg, B. B., Lassau, N., Leen, E. L., Mattrey, R. F., Moriyasu, F., Solbiati, L., Weskott, H. P., Xu, H. X., World Federation for Ultrasound in, M., & European Federation of Societies for, U. (2013). Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol, 39(2), 187-210. https://doi.org/10.1016/j.ultrasmedbio.2012.09.002

Conlon, K. C., Labow, D., Leung, D., Smith, A., Jarnagin, W., Coit, D. G., Merchant, N., & Brennan, M. F. (2001). Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg, 234(4), 487-493; discussion 493-484. https://www.ncbi.nlm.nih.gov/pubmed/11573042

Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J. L., Gourgou-Bourgade, S., de la Fouchardière, C., Bennouna, J., Bachet, J. B., Khemissa-Akouz, F., Péré-Vergé, D., Delbaldo, C., Assenat, E., Chauffert, B., Michel, P., Montoto-Grillot, C., & Ducreux, M. (2011). FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med, 364(19), 1817-1825. https://doi.org/10.1056/NEJMoa1011923

Conroy, T., Hammel, P., Hebbar, M., Ben Abdelghani, M., Wei, A. C., Raoul, J. L., Choné, L., Francois, E., Artru, P., Biagi, J. J., Lecomte, T., Assenat, E., Faroux, R., Ychou, M., Volet, J., Sauvanet, A., Breysacher, G., Di Fiore, F., Cripps, C., Kavan, P., Texereau, P., Bouhier-Leporrier, K., Khemissa-Akouz, F., Legoux, J. L., Juzyna, B., Gourgou, S., O'Callaghan, C. J., Jouffroy-Zeller, C., Rat, P., Malka, D., Castan, F., & Bachet, J. B. (2018). FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. N Engl J Med, 379(25), 2395-2406. https://doi.org/10.1056/NEJMoa1809775

Coppola, A., Stauffer, J. A., & Asbun, H. J. (2016). Laparoscopic pancreatoduodenectomy: current status and future directions. Updates Surg, 68(3), 217-224. https://doi.org/10.1007/s13304-016-0402-z

Corral, J. E., Mareth, K. F., Riegert-Johnson, D. L., Das, A., & Wallace, M. B. (2019). Diagnostic Yield From Screening Asymptomatic Individuals at High Risk for Pancreatic Cancer: A Meta-analysis of Cohort Studies. Clin Gastroenterol Hepatol, 17(1), 41-53. https://doi.org/10.1016/j.cgh.2018.04.065

Costamagna, G., Tringali, A., Spicak, J., Mutignani, M., Shaw, J., Roy, A., Johnsson, E., De Moura, E. G., Cheng, S., Ponchon, T., Bittinger, M., Messmann, H., Neuhaus, H., Schumacher, B., Laugier, R., Saarnio, J., & Ariqueta, F. I. (2012). Treatment of malignant gastroduodenal obstruction with a nitinol self-expanding metal stent: an international prospective multicentre registry. Dig Liver Dis, 44(1), 37-43. https://doi.org/10.1016/j.dld.2011.08.012

Coupland, V. H., Konfortion, J., Jack, R. H., Allum, W., Kocher, H. M., Riaz, S. P., Luchtenborg, M., & Moller, H. (2016). Resection rate, hospital procedure volume and survival in pancreatic cancer patients in England: Population-based study, 2005-2009. Eur J Surg Oncol, 42(2), 190-196. https://doi.org/10.1016/j.ejso.2015.11.003

Cramp, F., & Daniel, J. (2008). Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev(2), CD006145. https://doi.org/10.1002/14651858.CD006145.pub2

Crippa, S., Cirocchi, R., Randolph, J., Partelli, S., Belfiori, G., Piccioli, A., Parisi, A., & Falconi, M. (2016). Pancreaticojejunostomy is comparable to pancreaticogastrostomy after pancreaticoduodenectomy: an updated meta-analysis of randomized controlled trials. Langenbecks Arch Surg, 401(4), 427-437. https://doi.org/10.1007/s00423-016-1418-z

Cui, Y., & Andersen, D. K. (2011). Pancreatogenic diabetes: special considerations for management. Pancreatology, 11(3), 279-294. https://doi.org/10.1159/000329188

Cunningham, D., Chau, I., Stocken, D. D., Valle, J. W., Smith, D., Steward, W., Harper, P. G., Dunn, J., Tudur-Smith, C., West, J., Falk, S., Crellin, A., Adab, F., Thompson, J., Leonard, P., Ostrowski, J., Eatock, M., Scheithauer, W., Herrmann, R., & Neoptolemos, J. P. (2009). Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol, 27(33), 5513-5518. https://doi.org/10.1200/jco.2009.24.2446

De Hert, S., Imberger, G., Carlisle, J., Diemunsch, P., Fritsch, G., Moppett, I., Solca, M., Staender, S., Wappler, F., Smith, A., & Task Force on Preoperative Evaluation of the Adult Noncardiac Surgery Patient of the European Society of, A. (2011). Preoperative evaluation of the adult patient undergoing non-cardiac surgery: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol, 28(10), 684-722. https://doi.org/10.1097/EJA.0b013e3283499e3b

de Jong, K., Nio, C. Y., Hermans, J. J., Dijkgraaf, M. G., Gouma, D. J., van Eijck, C. H., van Heel, E., Klass, G., Fockens, P., & Bruno, M. J. (2010). High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol, 8(9), 806-811. https://doi.org/10.1016/j.cgh.2010.05.017

de Wilde, R. F., Besselink, M. G., van der Tweel, I., de Hingh, I. H., van Eijck, C. H., Dejong, C. H., Porte, R. J., Gouma, D. J., Busch, O. R., Molenaar, I. Q., & Dutch Pancreatic Cancer, G. (2012). Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality. Br J Surg, 99(3), 404-410. https://doi.org/10.1002/bjs.8664

Del Chiaro, M., Ateeb, Z., Hansson, M. R., Rangelova, E., Segersvard, R., Kartalis, N., Ansorge, C., Lohr, M. J., Arnelo, U., & Verbeke, C. (2017). Survival Analysis and Risk for Progression of Intraductal Papillary Mucinous Neoplasia of the Pancreas (IPMN) Under Surveillance: A Single-Institution Experience. Ann Surg Oncol, 24(4), 1120-1126. https://doi.org/10.1245/s10434-016-5661-x

Del Chiaro, M., Beckman, R., Ateeb, Z., Orsini, N., Rezaee, N., Manos, L., Valente, R., Yuan, C., Ding, D., Margonis, G. A., Yin, L., Cameron, J. L., Makary, M. A., Burkhart, R. A., Weiss, M. J., He, J., Arnelo, U., Yu, J., & Wolfgang, C. L. (2020). Main Duct Dilatation Is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg, 6, 1118-1124. https://doi.org/10.1097/sla.0000000000003174

Del Chiaro, M., Segersvärd, R., Rangelova, E., Coppola, A., Scandavini, C. M., Ansorge, C., Verbeke, C., & Blomberg, J. (2015). Cattell-Braasch Maneuver Combined with Artery-First Approach for Superior Mesenteric-Portal Vein Resection During Pancreatectomy. J Gastrointest Surg, 19(12), 2264-2268. https://doi.org/10.1007/s11605-015-2958-1

Del Chiaro, M., Verbeke, C. S., Kartalis, N., Pozzi Mucelli, R., Gustafsson, P., Hansson, J., Haas, S. L., Segersvard, R., Andren-Sandberg, A., & Lohr, J. M. (2015). Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer. JAMA Surg, 150(6), 512-518. https://doi.org/10.1001/jamasurg.2014.3852

Del Chiaro, M., Zerbi, A., Falconi, M., Bertacca, L., Polese, M., Sartori, N., Boggi, U., Casari, G., Longoni, B. M., Salvia, R., Caligo, M. A., Di Carlo, V., Pederzoli, P., Presciuttini, S., & Mosca, F. (2007). Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma. Pancreatology, 7(5-6), 459-469. https://doi.org/10.1159/000108963

Delpero, J. R., Bachellier, P., Regenet, N., Le Treut, Y. P., Paye, F., Carrere, N., Sauvanet, A., Autret, A., Turrini, O., Monges-Ranchin, G., & Boher, J. M. (2014). Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens. HPB (Oxford), 16(1), 20-33. https://doi.org/10.1111/hpb.12061

Diener, M. K., Seiler, C. M., Rossion, I., Kleeff, J., Glanemann, M., Butturini, G., Tomazic, A., Bruns, C. J., Busch, O. R., Farkas, S., Belyaev, O., Neoptolemos, J. P., Halloran, C., Keck, T., Niedergethmann, M., Gellert, K., Witzigmann, H., Kollmar, O., Langer, P., Steger, U., Neudecker, J., Berrevoet, F., Ganzera, S., Heiss, M. M., Luntz, S. P., Bruckner, T., Kieser, M., & Buchler, M. W. (2011). Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial. Lancet, 377(9776), 1514-1522. https://doi.org/10.1016/S0140-6736(11)60237-7

Dominguez-Munoz, J. E., Iglesias-Garcia, J., Iglesias-Rey, M., & Vilarino-Insua, M. (2006). Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts. Gut, 55(7), 1056-1057. https://doi.org/10.1136/gut.2006.094912

Domínguez-Muñoz, J. E., Nieto-Garcia, L., López-Díaz, J., Lariño-Noia, J., Abdulkader, I., & Iglesias-Garcia, J. (2018). Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis. BMC Cancer, 18(1), 534. https://doi.org/10.1186/s12885-018-4439-x

Duffy, M. J., Sturgeon, C., Lamerz, R., Haglund, C., Holubec, V. L., Klapdor, R., Nicolini, A., Topolcan, O., & Heinemann, V. (2010). Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol, 21(3), 441-447. https://doi.org/10.1093/annonc/mdp332

Dumonceau, J. M., Polkowski, M., Larghi, A., Vilmann, P., Giovannini, M., Frossard, J. L., Heresbach, D., Pujol, B., Fernandez-Esparrach, G., Vazquez-Sequeiros, E., Gines, A., & European Society of Gastrointestinal, E. (2011). Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy, 43(10), 897-912. https://doi.org/10.1055/s-0030-1256754

Dunschede, F., Will, L., von Langsdorf, C., Mohler, M., Galle, P. R., Otto, G., Vahl, C. F., & Junginger, T. (2010). Treatment of metachronous and simultaneous liver metastases of pancreatic cancer. Eur Surg Res, 44(3-4), 209-213. https://doi.org/10.1159/000313532

Elliott, I. A., Dann, A. M., Ghukasyan, R., Damato, L., Girgis, M. D., King, J. C., Hines, O. J., Reber, H. A., & Donahue, T. R. (2018). Pasireotide does not prevent postoperative pancreatic fistula: a prospective study. HPB (Oxford), 20(5), 418-422. https://doi.org/10.1016/j.hpb.2017.10.018

Engholm, G., Ferlay, J., Christensen, N., Bray, F., Gjerstorff, M. L., Klint, A., Kotlum, J. E., Olafsdottir, E., Pukkala, E., & Storm, H. H. (2010). NORDCAN--a Nordic tool for cancer information, planning, quality control and research. Acta Oncol, 49(5), 725-736. https://doi.org/10.3109/02841861003782017

Eppsteiner, R. W., Csikesz, N. G., McPhee, J. T., Tseng, J. F., & Shah, S. A. (2009). Surgeon volume impacts hospital mortality for pancreatic resection. Ann Surg, 249(4), 635-640. https://doi.org/10.1097/SLA.0b013e31819ed958

Eppsteiner, R. W., Csikesz, N. G., Simons, J. P., Tseng, J. F., & Shah, S. A. (2008). High volume and outcome after liver resection: surgeon or center? J Gastrointest Surg, 12(10), 1709-1716; discussion 1716. https://doi.org/10.1007/s11605-008-0627-3

Eshuis, W. J., Hermanides, J., van Dalen, J. W., van Samkar, G., Busch, O. R., van Gulik, T. M., DeVries, J. H., Hoekstra, J. B., & Gouma, D. J. (2011). Early postoperative hyperglycemia is associated with postoperative complications after pancreatoduodenectomy. Ann Surg, 253(4), 739-744. https://doi.org/10.1097/SLA.0b013e31820b4bfc

Ethun, C. G., & Kooby, D. A. (2016). The importance of surgical margins in pancreatic cancer. J Surg Oncol, 113(3), 283-288. https://doi.org/10.1002/jso.24092

European Study Group on Cystic Tumours of the Pancreas. (2018). European evidence-based guidelines on pancreatic cystic neoplasms. Gut, 67(5), 789-804. https://doi.org/10.1136/gutjnl-2018-316027

Farnell, M. B., Aranha, G. V., Nimura, Y., & Michelassi, F. (2008). The role of extended lymphadenectomy for adenocarcinoma of the head of the pancreas: strength of the evidence. J Gastrointest Surg, 12(4), 651-656. https://doi.org/10.1007/s11605-007-0451-1

Fattahi, R., Balci, N. C., Perman, W. H., Hsueh, E. C., Alkaade, S., Havlioglu, N., & Burton, F. R. (2009). Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging, 29(2), 350-356. https://doi.org/10.1002/jmri.21651

Ferrone, C. R., Finkelstein, D. M., Thayer, S. P., Muzikansky, A., Fernandez-delCastillo, C., & Warshaw, A. L. (2006). Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol, 24(18), 2897-2902. https://doi.org/10.1200/JCO.2005.05.3934

Finlayson, E. V., & Birkmeyer, J. D. (2003). Effects of hospital volume on life expectancy after selected cancer operations in older adults: a decision analysis. J Am Coll Surg, 196(3), 410-417. https://doi.org/10.1016/S1072-7515(02)01753-2

Finlayson, E. V., Goodney, P. P., & Birkmeyer, J. D. (2003). Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg, 138(7), 721-725; discussion 726. https://doi.org/10.1001/archsurg.138.7.721

Fischer, M., Matsuo, K., Gonen, M., Grant, F., Dematteo, R. P., D'Angelica, M. I., Mascarenhas, J., Brennan, M. F., Allen, P. J., Blumgart, L. H., & Jarnagin, W. R. (2010). Relationship between intraoperative fluid administration and perioperative outcome after pancreaticoduodenectomy: results of a prospective randomized trial of acute normovolemic hemodilution compared with standard intraoperative management. Ann Surg, 252(6), 952-958. https://doi.org/10.1097/SLA.0b013e3181ff36b1

Fletcher, G. F., Balady, G., Froelicher, V. F., Hartley, L. H., Haskell, W. L., & Pollock, M. L. (1995). Exercise standards. A statement for healthcare professionals from the American Heart Association. Writing Group. Circulation, 91(2), 580-615. https://doi.org/10.1161/01.cir.91.2.580

Fong, Y., Gonen, M., Rubin, D., Radzyner, M., & Brennan, M. F. (2005). Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg, 242(4), 540-544; discussion 544-547. http://www.ncbi.nlm.nih.gov/pubmed/16192814

Frozanpor, F., Loizou, L., Ansorge, C., Segersvard, R., Lundell, L., & Albiin, N. (2012). Preoperative pancreas CT/MRI characteristics predict fistula rate after pancreaticoduodenectomy. World J Surg, 36(8), 1858-1865. https://doi.org/10.1007/s00268-012-1567-3

Fukuda, S., Oussoultzoglou, E., Bachellier, P., Rosso, E., Nakano, H., Audet, M., & Jaeck, D. (2007). Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma. Arch Surg, 142(2), 172-179; discussion 180. https://doi.org/10.1001/archsurg.142.2.172

Fusaroli, P., Spada, A., Mancino, M. G., & Caletti, G. (2010). Contrast harmonic echo-endoscopic ultrasound improves accuracy in diagnosis of solid pancreatic masses. Clin Gastroenterol Hepatol, 8(7), 629-634 e621-622. https://doi.org/10.1016/j.cgh.2010.04.012

Gangi, S., Fletcher, J. G., Nathan, M. A., Christensen, J. A., Harmsen, W. S., Crownhart, B. S., & Chari, S. T. (2004). Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. AJR Am J Roentgenol, 182(4), 897-903. https://doi.org/10.2214/ajr.182.4.1820897

Genkinger, J. M., Spiegelman, D., Anderson, K. E., Bergkvist, L., Bernstein, L., van den Brandt, P. A., English, D. R., Freudenheim, J. L., Fuchs, C. S., Giles, G. G., Giovannucci, E., Hankinson, S. E., Horn-Ross, P. L., Leitzmann, M., Mannisto, S., Marshall, J. R., McCullough, M. L., Miller, A. B., Reding, D. J., Robien, K., Rohan, T. E., Schatzkin, A., Stevens, V. L., Stolzenberg-Solomon, R. Z., Verhage, B. A., Wolk, A., Ziegler, R. G., & Smith-Warner, S. A. (2009). Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer Epidemiol Biomarkers Prev, 18(3), 765-776. https://doi.org/10.1158/1055-9965.EPI-08-0880

Gerritsen, A., Besselink, M. G., Gouma, D. J., Steenhagen, E., Borel Rinkes, I. H., & Molenaar, I. Q. (2013). Systematic review of five feeding routes after pancreatoduodenectomy. Br J Surg, 100(5), 589-598; discussion 599. https://doi.org/10.1002/bjs.9049

Ghaferi, A. A., Birkmeyer, J. D., & Dimick, J. B. (2011). Hospital volume and failure to rescue with high-risk surgery. Med Care, 49(12), 1076-1081. https://doi.org/10.1097/MLR.0b013e3182329b97

Ghaferi, A. A., Osborne, N. H., Birkmeyer, J. D., & Dimick, J. B. (2010). Hospital characteristics associated with failure to rescue from complications after pancreatectomy. J Am Coll Surg, 211(3), 325-330. https://doi.org/10.1016/j.jamcollsurg.2010.04.025

Gianotti, L., Besselink, M. G., Sandini, M., Hackert, T., Conlon, K., Gerritsen, A., Griffin, O., Fingerhut, A., Probst, P., Abu Hilal, M., Marchegiani, G., Nappo, G., Zerbi, A., Amodio, A., Perinel, J., Adham, M., Raimondo, M., Asbun, H. J., Sato, A., Takaori, K., Shrikhande, S. V., Del Chiaro, M., Bockhorn, M., Izbicki, J. R., Dervenis, C., Charnley, R. M., Martignoni, M. E., Friess, H., de Pretis, N., Radenkovic, D., Montorsi, M., Sarr, M. G., Vollmer, C. M., Frulloni, L., Büchler, M. W., & Bassi, C. (2018). Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS). Surgery, 164(5), 1035-1048. https://doi.org/10.1016/j.surg.2018.05.040

Gill, S., Ko, Y. J., Cripps, C., Beaudoin, A., Dhesy-Thind, S., Zulfiqar, M., Zalewski, P., Do, T., Cano, P., Lam, W. Y. H., Dowden, S., Grassin, H., Stewart, J., & Moore, M. (2016). PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy. J Clin Oncol, 34(32), 3914-3920. https://doi.org/10.1200/jco.2016.68.5776

Gillen, S., Schuster, T., Friess, H., & Kleeff, J. (2012). Palliative resections versus palliative bypass procedures in pancreatic cancer--a systematic review. Am J Surg, 203(4), 496-502. https://doi.org/10.1016/j.amjsurg.2011.05.004

Gillen, S., Schuster, T., Meyer Zum Buschenfelde, C., Friess, H., & Kleeff, J. (2010). Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med, 7(4), e1000267. https://doi.org/10.1371/journal.pmed.1000267

Glazer, E. S., Hornbrook, M. C., & Krouse, R. S. (2014). A meta-analysis of randomized trials: immediate stent placement vs. surgical bypass in the palliative management of malignant biliary obstruction. J Pain Symptom Manage, 47(2), 307-314. https://doi.org/10.1016/j.jpainsymman.2013.03.013

Gleisner, A. L., Assumpcao, L., Cameron, J. L., Wolfgang, C. L., Choti, M. A., Herman, J. M., Schulick, R. D., & Pawlik, T. M. (2007). Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified? Cancer, 110(11), 2484-2492. https://doi.org/10.1002/cncr.23074

Goggins, M. (2005). Molecular markers of early pancreatic cancer. J Clin Oncol, 23(20), 4524-4531. https://doi.org/10.1200/JCO.2005.19.711

Goggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., Fockens, P., Gress, T. M., van Hooft, J. E., Hruban, R. H., Kastrinos, F., Klein, A., Lennon, A. M., Lucas, A., Park, W., Rustgi, A., Simeone, D., Stoffel, E., Vasen, H. F. A., Cahen, D. L., Canto, M. I., & Bruno, M. (2020). Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut, 69(1), 7-17. https://doi.org/10.1136/gutjnl-2019-319352

Golan, T., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M. J., Park, J. O., Hochhauser, D., Arnold, D., Oh, D. Y., Reinacher-Schick, A., Tortora, G., Algül, H., O'Reilly, E. M., McGuinness, D., Cui, K. Y., Schlienger, K., Locker, G. Y., & Kindler, H. L. (2019). Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. N Engl J Med, 381(4), 317-327. https://doi.org/10.1056/NEJMoa1903387

Gong, H., Ma, R., Gong, J., Cai, C., Song, Z., & Xu, B. (2016). Distal Pancreatectomy With En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis. Medicine (Baltimore), 95(10), e3061. https://doi.org/10.1097/MD.0000000000003061

Goodney, P. P., Stukel, T. A., Lucas, F. L., Finlayson, E. V., & Birkmeyer, J. D. (2003). Hospital volume, length of stay, and readmission rates in high-risk surgery. Ann Surg, 238(2), 161-167. https://doi.org/10.1097/01.SLA.0000081094.66659.c3

Goonetilleke, K. S., & Siriwardena, A. K. (2007). Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol, 33(3), 266-270. https://doi.org/10.1016/j.ejso.2006.10.004

Gouma, D. J., Busch, O. R., & Van Gulik, T. M. (2006). Pancreatic carcinoma: palliative surgical and endoscopic treatment. HPB (Oxford), 8(5), 369-376. https://doi.org/10.1080/13651820600804021

Gouma, D. J., van Geenen, R. C., van Gulik, T. M., de Haan, R. J., de Wit, L. T., Busch, O. R., & Obertop, H. (2000). Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg, 232(6), 786-795. http://www.ncbi.nlm.nih.gov/pubmed/11088073

Gregoratos, G. (2008). Current guideline-based preoperative evaluation provides the best management of patients undergoing noncardiac surgery. Circulation, 117(24), 3134-3144; discussion 3134. https://doi.org/10.1161/CIRCULATIONAHA.107.761759

Guarracino, F., Baldassarri, R., & Priebe, H. J. (2015). Revised ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. Implications for preoperative clinical evaluation. Minerva Anestesiol, 81(2), 226-233. http://www.ncbi.nlm.nih.gov/pubmed/25384693

Guerrini, G. P., Soliani, P., D'Amico, G., Di Benedetto, F., Negri, M., Piccoli, M., Ruffo, G., Orti-Rodriguez, R. J., Pissanou, T., & Fusai, G. (2016). Pancreaticojejunostomy Versus Pancreaticogastrostomy After Pancreaticoduodenectomy: An Up-to-date Meta-Analysis. J Invest Surg, 29(3), 175-184. https://doi.org/10.3109/08941939.2015.1093047

Gumbs, A. A., Rodriguez Rivera, A. M., Milone, L., & Hoffman, J. P. (2011). Laparoscopic pancreatoduodenectomy: a review of 285 published cases. Ann Surg Oncol, 18(5), 1335-1341. https://doi.org/10.1245/s10434-010-1503-4

Gupta, K., Perez-Miranda, M., Kahaleh, M., Artifon, E. L., Itoi, T., Freeman, M. L., de-Serna, C., Sauer, B., & Giovannini, M. (2014). Endoscopic ultrasound-assisted bile duct access and drainage: multicenter, long-term analysis of approach, outcomes, and complications of a technique in evolution. J Clin Gastroenterol, 48(1), 80-87. https://doi.org/10.1097/MCG.0b013e31828c6822

Gurusamy, K. S., Kumar, S., & Davidson, B. R. (2013). Prophylactic gastrojejunostomy for unresectable periampullary carcinoma. Cochrane Database Syst Rev(2), CD008533. https://doi.org/10.1002/14651858.CD008533.pub3

Haas, S. L., Ye, W., & Lohr, J. M. (2012). Alcohol consumption and digestive tract cancer. Curr Opin Clin Nutr Metab Care, 15(5), 457-467. https://doi.org/10.1097/MCO.0b013e3283566699

Hackert, T., Fritz, S., Klauss, M., Bergmann, F., Hinz, U., Strobel, O., Schneider, L., & Buchler, M. W. (2015). Main-duct Intraductal Papillary Mucinous Neoplasm: High Cancer Risk in Duct Diameter of 5 to 9 mm. Ann Surg, 262(5), 875-880; discussion 880-871. https://doi.org/10.1097/SLA.0000000000001462

Hackert, T., Probst, P., Knebel, P., Doerr-Harim, C., Bruckner, T., Klaiber, U., Werner, J., Schneider, L., Michalski, C. W., Strobel, O., Ulrich, A., Diener, M. K., & Büchler, M. W. (2018). Pylorus Resection Does Not Reduce Delayed Gastric Emptying After Partial Pancreatoduodenectomy: A Blinded Randomized Controlled Trial (PROPP Study, DRKS00004191). Ann Surg, 267(6), 1021-1027. https://doi.org/10.1097/sla.0000000000002480

Hackert, T., Sachsenmaier, M., Hinz, U., Schneider, L., Michalski, C. W., Springfeld, C., Strobel, O., Jäger, D., Ulrich, A., & Büchler, M. W. (2016). Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients. Ann Surg, 264(3), 457-463. https://doi.org/10.1097/sla.0000000000001850

Hamano, H., Kawa, S., Horiuchi, A., Unno, H., Furuya, N., Akamatsu, T., Fukushima, M., Nikaido, T., Nakayama, K., Usuda, N., & Kiyosawa, K. (2001). High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med, 344(10), 732-738. https://doi.org/10.1056/nejm200103083441005

Hamilton, N. A., Porembka, M. R., Johnston, F. M., Gao, F., Strasberg, S. M., Linehan, D. C., & Hawkins, W. G. (2012). Mesh reinforcement of pancreatic transection decreases incidence of pancreatic occlusion failure for left pancreatectomy: a single-blinded, randomized controlled trial. Ann Surg, 255(6), 1037-1042. https://doi.org/10.1097/SLA.0b013e31825659ef

Hanna, M. M., Gadde, R., Allen, C. J., Meizoso, J. P., Sleeman, D., Livingstone, A. S., Merchant, N., & Yakoub, D. (2016). Delayed gastric emptying after pancreaticoduodenectomy. J Surg Res, 202(2), 380-388. https://doi.org/10.1016/j.jss.2015.12.053

Harinck, F., Konings, I. C., Kluijt, I., Poley, J. W., van Hooft, J. E., van Dullemen, H. M., Nio, C. Y., Krak, N. C., Hermans, J. J., Aalfs, C. M., Wagner, A., Sijmons, R. H., Biermann, K., van Eijck, C. H., Gouma, D. J., Dijkgraaf, M. G., Fockens, P., & Bruno, M. J. (2016). A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals. Gut, 65(9), 1505-1513. https://doi.org/10.1136/gutjnl-2014-308008

Hartwig, W., Gluth, A., Hinz, U., Koliogiannis, D., Strobel, O., Hackert, T., Werner, J., & Büchler, M. W. (2016). Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer. Br J Surg, 103(12), 1683-1694. https://doi.org/10.1002/bjs.10221

Hartwig, W., Hackert, T., Hinz, U., Hassenpflug, M., Strobel, O., Buchler, M. W., & Werner, J. (2009). Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome. Ann Surg, 250(1), 81-87. https://doi.org/10.1097/SLA.0b013e3181ad657b

Hartwig, W., Schneider, L., Diener, M. K., Bergmann, F., Buchler, M. W., & Werner, J. (2009). Preoperative tissue diagnosis for tumours of the pancreas. Br J Surg, 96(1), 5-20. https://doi.org/10.1002/bjs.6407

Hartwig, W., Vollmer, C. M., Fingerhut, A., Yeo, C. J., Neoptolemos, J. P., Adham, M., Andrén-Sandberg, A., Asbun, H. J., Bassi, C., Bockhorn, M., Charnley, R., Conlon, K. C., Dervenis, C., Fernandez-Cruz, L., Friess, H., Gouma, D. J., Imrie, C. W., Lillemoe, K. D., Milićević, M. N., Montorsi, M., Shrikhande, S. V., Vashist, Y. K., Izbicki, J. R., & Büchler, M. W. (2014). Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS). Surgery, 156(1), 1-14. https://doi.org/10.1016/j.surg.2014.02.009

Hathaway, D. (1986). Effect of preoperative instruction on postoperative outcomes: a meta-analysis. Nursing research.

He, X. Y., Li, J. F., Yao, W. Y., & Yuan, Y. Z. (2013). Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma. Ann Surg Oncol, 20(12), 3809-3816. https://doi.org/10.1245/s10434-013-3095-2

Hemminki, K., & Li, X. (2003). Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer, 103(4), 525-530. https://doi.org/10.1002/ijc.10863

Hewitt, M. J., McPhail, M. J., Possamai, L., Dhar, A., Vlavianos, P., & Monahan, K. J. (2012). EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointest Endosc, 75(2), 319-331. https://doi.org/10.1016/j.gie.2011.08.049

Heye, T., Zausig, N., Klauss, M., Singer, R., Werner, J., Richter, G. M., Kauczor, H. U., & Grenacher, L. (2011). CT diagnosis of recurrence after pancreatic cancer: is there a pattern? World J Gastroenterol, 17(9), 1126-1134. https://doi.org/10.3748/wjg.v17.i9.1126

Hidalgo, M., Cascinu, S., Kleeff, J., Labianca, R., Lohr, J. M., Neoptolemos, J., Real, F. X., Van Laethem, J. L., & Heinemann, V. (2015). Addressing the challenges of pancreatic cancer: future directions for improving outcomes. Pancreatology, 15(1), 8-18. https://doi.org/10.1016/j.pan.2014.10.001

Hishinuma, S., Ogata, Y., Tomikawa, M., Ozawa, I., Hirabayashi, K., & Igarashi, S. (2006). Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg, 10(4), 511-518. https://doi.org/10.1016/j.gassur.2005.09.016

Holalkere, N. S., Sahani, D. V., Blake, M. A., Halpern, E. F., Hahn, P. F., & Mueller, P. R. (2006). Characterization of small liver lesions: Added role of MR after MDCT. J Comput Assist Tomogr, 30(4), 591-596. http://www.ncbi.nlm.nih.gov/pubmed/16845289

Hori, Y., Naitoh, I., Hayashi, K., Ban, T., Natsume, M., Okumura, F., Nakazawa, T., Takada, H., Hirano, A., Jinno, N., Togawa, S., Ando, T., Kataoka, H., & Joh, T. (2017). Predictors of outcomes in patients undergoing covered and uncovered self-expandable metal stent placement for malignant gastric outlet obstruction: a multicenter study. Gastrointest Endosc, 85(2), 340-348 e341. https://doi.org/10.1016/j.gie.2016.07.048

House, M. G., Gonen, M., Jarnagin, W. R., D'Angelica, M., DeMatteo, R. P., Fong, Y., Brennan, M. F., & Allen, P. J. (2007). Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg, 11(11), 1549-1555. https://doi.org/10.1007/s11605-007-0243-7

Huttner, F. J., Klotz, R., Ulrich, A., Buchler, M. W., & Diener, M. K. (2016). Antecolic versus retrocolic reconstruction after partial pancreaticoduodenectomy. Cochrane Database Syst Rev, 9, CD011862. https://doi.org/10.1002/14651858.CD011862.pub2

Huttner, F. J., Mihaljevic, A. L., Hackert, T., Ulrich, A., Buchler, M. W., & Diener, M. K. (2016). Effectiveness of Tachosil((R)) in the prevention of postoperative pancreatic fistula after distal pancreatectomy: a systematic review and meta-analysis. Langenbecks Arch Surg, 401(2), 151-159. https://doi.org/10.1007/s00423-016-1382-7

Huxley, R., Ansary-Moghaddam, A., Berrington de Gonzalez, A., Barzi, F., & Woodward, M. (2005). Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer, 92(11), 2076-2083. https://doi.org/10.1038/sj.bjc.6602619

IARC 2020. (2020). World Cancer Report: Cancer Research for Cancer Prevention. Lyon, France: International Agency for Research on Cancer,

. https://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-Cancer-Research-For-Cancer-Prevention-2020

Ichikawa, T., Sou, H., Araki, T., Arbab, A. S., Yoshikawa, T., Ishigame, K., Haradome, H., & Hachiya, J. (2001). Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology, 221(1), 107-116. https://doi.org/10.1148/radiol.2211001157

Ihse, I. (2003). The volume-outcome relationship in cancer surgery: a hard sell. Ann Surg, 238(6), 777-781. https://doi.org/10.1097/01.sla.0000098616.19622.af

Ihse, I., & Isaksson, G. (1984). Pancreatic carcinoma: diagnosis and treatment. Clin Gastroenterol, 13(3), 961-984. http://www.ncbi.nlm.nih.gov/pubmed/6207967

Insulander, J., Sanjeevi, S., Haghighi, M., Ivanics, T., Analatos, A., Lundell, L., Del Chiaro, M., Andren-Sandberg, A., & Ansorge, C. (2016). Prognosis following surgical bypass compared with laparotomy alone in unresectable pancreatic adenocarcinoma. Br J Surg, 103(9), 1200-1208. https://doi.org/10.1002/bjs.10190

Iodice, S., Gandini, S., Lohr, M., Lowenfels, A. B., & Maisonneuve, P. (2008). Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis. J Thromb Haemost, 6(5), 781-788. https://doi.org/10.1111/j.1538-7836.2008.02928.x

Iodice, S., Gandini, S., Maisonneuve, P., & Lowenfels, A. B. (2008). Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg, 393(4), 535-545. https://doi.org/10.1007/s00423-007-0266-2

Iwakawa, M., Noda, S., Yamada, S., Yamamoto, N., Miyazawa, Y., Yamazaki, H., Kawakami, Y., Matsui, Y., Tsujii, H., Mizoe, J., Oda, E., Fukunaga, Y., & Imai, T. (2006). Analysis of non-genetic risk factors for adverse skin reactions to radiotherapy among 284 breast cancer patients. Breast Cancer, 13(3), 300-307. http://www.ncbi.nlm.nih.gov/pubmed/16929125

Jacobs, E. J., Chanock, S. J., Fuchs, C. S., Lacroix, A., McWilliams, R. R., Steplowski, E., Stolzenberg-Solomon, R. Z., Arslan, A. A., Bueno-de-Mesquita, H. B., Gross, M., Helzlsouer, K., Petersen, G., Zheng, W., Agalliu, I., Allen, N. E., Amundadottir, L., Boutron-Ruault, M. C., Buring, J. E., Canzian, F., Clipp, S., Dorronsoro, M., Gaziano, J. M., Giovannucci, E. L., Hankinson, S. E., Hartge, P., Hoover, R. N., Hunter, D. J., Jacobs, K. B., Jenab, M., Kraft, P., Kooperberg, C., Lynch, S. M., Sund, M., Mendelsohn, J. B., Mouw, T., Newton, C. C., Overvad, K., Palli, D., Peeters, P. H., Rajkovic, A., Shu, X. O., Thomas, G., Tobias, G. S., Trichopoulos, D., Virtamo, J., Wactawski-Wende, J., Wolpin, B. M., Yu, K., & Zeleniuch-Jacquotte, A. (2010). Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Int J Cancer, 127(6), 1421-1428. https://doi.org/10.1002/ijc.25148

Jagsi, R., Griffith, K. A., Koelling, T., Roberts, R., & Pierce, L. J. (2007). Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer. Cancer, 109(4), 650-657. https://doi.org/10.1002/cncr.22452

Jais, B., Rebours, V., Malleo, G., Salvia, R., Fontana, M., Maggino, L., Bassi, C., Manfredi, R., Moran, R., Lennon, A. M., Zaheer, A., Wolfgang, C., Hruban, R., Marchegiani, G., Fernandez Del Castillo, C., Brugge, W., Ha, Y., Kim, M. H., Oh, D., Hirai, I., Kimura, W., Jang, J. Y., Kim, S. W., Jung, W., Kang, H., Song, S. Y., Kang, C. M., Lee, W. J., Crippa, S., Falconi, M., Gomatos, I., Neoptolemos, J., Milanetto, A. C., Sperti, C., Ricci, C., Casadei, R., Bissolati, M., Balzano, G., Frigerio, I., Girelli, R., Delhaye, M., Bernier, B., Wang, H., Jang, K. T., Song, D. H., Huggett, M. T., Oppong, K. W., Pererva, L., Kopchak, K. V., Del Chiaro, M., Segersvard, R., Lee, L. S., Conwell, D., Osvaldt, A., Campos, V., Aguero Garcete, G., Napoleon, B., Matsumoto, I., Shinzeki, M., Bolado, F., Fernandez, J. M., Keane, M. G., Pereira, S. P., Acuna, I. A., Vaquero, E. C., Angiolini, M. R., Zerbi, A., Tang, J., Leong, R. W., Faccinetto, A., Morana, G., Petrone, M. C., Arcidiacono, P. G., Moon, J. H., Choi, H. J., Gill, R. S., Pavey, D., Ouaissi, M., Sastre, B., Spandre, M., De Angelis, C. G., Rios-Vives, M. A., Concepcion-Martin, M., Ikeura, T., Okazaki, K., Frulloni, L., Messina, O., & Levy, P. (2016). Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut, 65(2), 305-312. https://doi.org/10.1136/gutjnl-2015-309638

Jeurnink, S. M., Steyerberg, E. W., van Hooft, J. E., van Eijck, C. H., Schwartz, M. P., Vleggaar, F. P., Kuipers, E. J., Siersema, P. D., & Dutch, S. S. G. (2010). Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc, 71(3), 490-499. https://doi.org/10.1016/j.gie.2009.09.042

Jeurnink, S. M., Steyerberg, E. W., Vleggaar, F. P., van Eijck, C. H., van Hooft, J. E., Schwartz, M. P., Kuipers, E. J., Siersema, P. D., & Dutch, S. S. G. (2011). Predictors of survival in patients with malignant gastric outlet obstruction: a patient-oriented decision approach for palliative treatment. Dig Liver Dis, 43(7), 548-552. https://doi.org/10.1016/j.dld.2011.01.017

Jia, L., Shang, Y. Y., Jiang, S. M., Xie, Q., Huang, Y. X., Xie, D. R., Huang, K. H., Zhi, F. C., & Li, Y. Y. (2009). [Relationship between symptoms of pancreatic cancer-related depression and quality of life of patients]. Zhonghua Yi Xue Za Zhi, 89(26), 1847-1849. http://www.ncbi.nlm.nih.gov/pubmed/19953932

Jiao, L., Berrington de Gonzalez, A., Hartge, P., Pfeiffer, R. M., Park, Y., Freedman, D. M., Gail, M. H., Alavanja, M. C., Albanes, D., Beane Freeman, L. E., Chow, W. H., Huang, W. Y., Hayes, R. B., Hoppin, J. A., Ji, B. T., Leitzmann, M. F., Linet, M. S., Meinhold, C. L., Schairer, C., Schatzkin, A., Virtamo, J., Weinstein, S. J., Zheng, W., & Stolzenberg-Solomon, R. Z. (2010). Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control, 21(8), 1305-1314. https://doi.org/10.1007/s10552-010-9558-x

Johnston, W. C., Hoen, H. M., Cassera, M. A., Newell, P. H., Hammill, C. W., Hansen, P. D., & Wolf, R. F. (2016). Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base. HPB (Oxford), 18(1), 21-28. https://doi.org/10.1016/j.hpb.2015.07.009

Kaminsky, P. M., & Mezhir, J. J. (2013). Intraperitoneal drainage after pancreatic resection: a review of the evidence. J Surg Res, 184(2), 925-930. https://doi.org/10.1016/j.jss.2013.05.092

Kamisawa, T., Shimosegawa, T., Okazaki, K., Nishino, T., Watanabe, H., Kanno, A., Okumura, F., Nishikawa, T., Kobayashi, K., Ichiya, T., Takatori, H., Yamakita, K., Kubota, K., Hamano, H., Okamura, K., Hirano, K., Ito, T., Ko, S. B., & Omata, M. (2009). Standard steroid treatment for autoimmune pancreatitis. Gut, 58(11), 1504-1507. https://doi.org/10.1136/gut.2008.172908

Kanda, M., Fujii, T., Nagai, S., Kodera, Y., Kanzaki, A., Sahin, T. T., Hayashi, M., Yamada, S., Sugimoto, H., Nomoto, S., Takeda, S., Morita, S., & Nakao, A. (2011). Pattern of lymph node metastasis spread in pancreatic cancer. Pancreas, 40(6), 951-955. https://doi.org/10.1097/MPA.0b013e3182148342

Kaneoka, Y., Yamaguchi, A., & Isogai, M. (2009). Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection. Surgery, 145(4), 417-425. https://doi.org/10.1016/j.surg.2008.12.009

Kang, E., Gillespie, B. M., Tobiano, G., & Chaboyer, W. (2018). Discharge education delivered to general surgical patients in their management of recovery post discharge–a systematic mixed studies review: Authors. International journal of nursing studies.

Karlson, B. M., Forsman, C. A., Wilander, E., Skogseid, B., Lindgren, P. G., Jacobson, G., & Rastad, J. (1996). Efficiency of percutaneous core biopsy in pancreatic tumor diagnosis. Surgery, 120(1), 75-79. http://www.ncbi.nlm.nih.gov/pubmed/8693427

Kartalis, N. (2018). CT and MRI of pancreatic cancer: there is no rose without a thorn! Eur Radiol, 28(8), 3482-3483. https://doi.org/10.1007/s00330-018-5486-z

Kartalis, N., Lindholm, T. L., Aspelin, P., Permert, J., & Albiin, N. (2009). Diffusion-weighted magnetic resonance imaging of pancreas tumours. Eur Radiol, 19(8), 1981-1990. https://doi.org/10.1007/s00330-009-1384-8

Kato, K., Nihashi, T., Ikeda, M., Abe, S., Iwano, S., Itoh, S., Shimamoto, K., & Naganawa, S. (2013). Limited efficacy of (18)F-FDG PET/CT for differentiation between metastasis-free pancreatic cancer and mass-forming pancreatitis. Clin Nucl Med, 38(6), 417-421. https://doi.org/10.1097/RLU.0b013e3182817d9d

Kauffmann, E. F., Napoli, N., Menonna, F., Vistoli, F., Amorese, G., Campani, D., Pollina, L. E., Funel, N., Cappelli, C., Caramella, D., & Boggi, U. (2016). Robotic pancreatoduodenectomy with vascular resection. Langenbecks Arch Surg, 401(8), 1111-1122. https://doi.org/10.1007/s00423-016-1499-8

Kaufman, E. L., Jacobson, J. S., Hershman, D. L., Desai, M., & Neugut, A. I. (2008). Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol, 26(3), 392-398. https://doi.org/10.1200/JCO.2007.13.3033

Kauhanen, S. P., Komar, G., Seppanen, M. P., Dean, K. I., Minn, H. R., Kajander, S. A., Rinta-Kiikka, I., Alanen, K., Borra, R. J., Puolakkainen, P. A., Nuutila, P., & Ovaska, J. T. (2009). A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Ann Surg, 250(6), 957-963. https://doi.org/10.1097/SLA.0b013e3181b2fafa

Kawa, S. (2016). Current Concepts and Diagnosis of IgG4-Related Pancreatitis (Type 1 AIP). Semin Liver Dis, 36(3), 257-273. https://doi.org/10.1055/s-0036-1584318

Keane, M. G., Horsfall, L., Rait, G., & Pereira, S. P. (2014). A case-control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer. BMJ Open, 4(11), e005720. https://doi.org/10.1136/bmjopen-2014-005720

Keck, T., Wellner, U. F., Bahra, M., Klein, F., Sick, O., Niedergethmann, M., Wilhelm, T. J., Farkas, S. A., Borner, T., Bruns, C., Kleespies, A., Kleeff, J., Mihaljevic, A. L., Uhl, W., Chromik, A., Fendrich, V., Heeger, K., Padberg, W., Hecker, A., Neumann, U. P., Junge, K., Kalff, J. C., Glowka, T. R., Werner, J., Knebel, P., Piso, P., Mayr, M., Izbicki, J., Vashist, Y., Bronsert, P., Bruckner, T., Limprecht, R., Diener, M. K., Rossion, I., Wegener, I., & Hopt, U. T. (2016). Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767): Perioperative and Long-term Results of a Multicenter Randomized Controlled Trial. Ann Surg, 263(3), 440-449. https://doi.org/10.1097/SLA.0000000000001240

Kelly, L., & Vincent, D. (2011). The dimensions of nursing surveillance: a concept analysis. Journal of advanced nursing, 67(3), 652-661.

Keulers, B. J., Scheltinga, M. R., Houterman, S., Van Der Wilt, G. J., & Spauwen, P. H. (2008). Surgeons underestimate their patients' desire for preoperative information. World J Surg, 32(6), 964-970. https://doi.org/10.1007/s00268-008-9581-1

Kim, C. G., Choi, I. J., Lee, J. Y., Cho, S. J., Park, S. R., Lee, J. H., Ryu, K. W., Kim, Y. W., & Park, Y. I. (2010). Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study. Gastrointest Endosc, 72(1), 25-32. https://doi.org/10.1016/j.gie.2010.01.039

Kim, J. E., Lee, K. T., Lee, J. K., Paik, S. W., Rhee, J. C., & Choi, K. W. (2004). Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol, 19(2), 182-186. http://www.ncbi.nlm.nih.gov/pubmed/14731128

Kim, J. H., Lee, S. C., Oh, S. Y., Song, S. Y., Lee, N., Nam, E. M., Lee, S., Hwang, I. G., Lee, H. R., Lee, K. T., Bae, S. B., Kim, H. J., Jang, J. S., Lim, D. H., Lee, H. W., Kang, S. Y., & Kang, J. H. (2018). Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study. Cancer Commun (Lond), 38(1), 32. https://doi.org/10.1186/s40880-018-0304-1

Kim, J. H., Park, S. H., Yu, E. S., Kim, M. H., Kim, J., Byun, J. H., Lee, S. S., Hwang, H. J., Hwang, J. Y., Lee, S. S., & Lee, M. G. (2010). Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology, 257(1), 87-96. https://doi.org/10.1148/radiol.10100015

Kim, S. C., Kim, Y. H., Park, K. M., & Lee, Y. J. (2012). Pancreatic cancer surgery: the state of the art. Curr Drug Targets, 13(6), 764-771. http://www.ncbi.nlm.nih.gov/pubmed/22458522

King, E. J., Haboubi, H., Evans, D., Baker, I., Bain, S. C., & Stephens, J. W. (2012). The management of diabetes in terminal illness related to cancer. QJM, 105(1), 3-9. https://doi.org/10.1093/qjmed/hcr167

Kinney, T. (2010). Evidence-based imaging of pancreatic malignancies. Surg Clin North Am, 90(2), 235-249. https://doi.org/10.1016/j.suc.2009.12.003

Klapman, J., & Malafa, M. P. (2008). Early detection of pancreatic cancer: why, who, and how to screen. Cancer Control, 15(4), 280-287. http://www.ncbi.nlm.nih.gov/pubmed/18813195

Klein, A. P., Brune, K. A., Petersen, G. M., Goggins, M., Tersmette, A. C., Offerhaus, G. J., Griffin, C., Cameron, J. L., Yeo, C. J., Kern, S., & Hruban, R. H. (2004). Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res, 64(7), 2634-2638. http://www.ncbi.nlm.nih.gov/pubmed/15059921

Klinkenbijl, J. H., Jeekel, J., Schmitz, P. I., Rombout, P. A., Nix, G. A., Bruining, H. A., & van Blankenstein, M. (1993). Carcinoma of the pancreas and periampullary region: palliation versus cure. Br J Surg, 80(12), 1575-1578. http://www.ncbi.nlm.nih.gov/pubmed/7507785

Kohan, G., Ocampo, C. G., Zandalazini, H. I., Klappenbach, R., Yazyi, F., Ditulio, O., Coturel, A., Canullán, C., Porras, L. T., & Rodriguez, J. A. (2015). Laparoscopic hepaticojejunostomy and gastrojejunostomy for palliative treatment of pancreatic head cancer in 48 patients. Surg Endosc, 29(7), 1970-1975. https://doi.org/10.1007/s00464-014-3894-y

Koizumi, M., Sata, N., Kasahara, N., Morishima, K., Sasanuma, H., Sakuma, Y., Shimizu, A., Hyodo, M., & Yasuda, Y. (2010). Remnant pancreatectomy for recurrent or metachronous pancreatic carcinoma detected by FDG-PET: two case reports. JOP, 11(1), 36-40. http://www.ncbi.nlm.nih.gov/pubmed/20065550

Kooby, D. A., Gillespie, T., Bentrem, D., Nakeeb, A., Schmidt, M. C., Merchant, N. B., Parikh, A. A., Martin, R. C., 2nd, Scoggins, C. R., Ahmad, S., Kim, H. J., Park, J., Johnston, F., Strouch, M. J., Menze, A., Rymer, J., McClaine, R., Strasberg, S. M., Talamonti, M. S., Staley, C. A., McMasters, K. M., Lowy, A. M., Byrd-Sellers, J., Wood, W. C., & Hawkins, W. G. (2008). Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches. Ann Surg, 248(3), 438-446. https://doi.org/10.1097/SLA.0b013e318185a990

Kotwall, C. A., Maxwell, J. G., Brinker, C. C., Koch, G. G., & Covington, D. L. (2002). National estimates of mortality rates for radical pancreaticoduodenectomy in 25,000 patients. Ann Surg Oncol, 9(9), 847-854. http://www.ncbi.nlm.nih.gov/pubmed/12417505

Kristensen, S. D., Knuuti, J., Saraste, A., Anker, S., Botker, H. E., De Hert, S., Ford, I., Gonzalez Juanatey, J. R., Gorenek, B., Heyndrickx, G. R., Hoeft, A., Huber, K., Iung, B., Kjeldsen, K. P., Longrois, D., Luescher, T. F., Pierard, L., Pocock, S., Price, S., Roffi, M., Sirnes, P. A., Uva, M. S., Voudris, V., Funck-Brentano, C., & Authors/Task Force, M. (2014). 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol, 31(10), 517-573. https://doi.org/10.1097/EJA.0000000000000150

Kromrey, M. L., Bülow, R., Hübner, J., Paperlein, C., Lerch, M. M., Ittermann, T., Völzke, H., Mayerle, J., & Kühn, J. P. (2018). Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut, 67(1), 138-145. https://doi.org/10.1136/gutjnl-2016-313127

Kunda, R., Perez-Miranda, M., Will, U., Ullrich, S., Brenke, D., Dollhopf, M., Meier, M., & Larghi, A. (2016). EUS-guided choledochoduodenostomy for malignant distal biliary obstruction using a lumen-apposing fully covered metal stent after failed ERCP. Surg Endosc, 30(11), 5002-5008. https://doi.org/10.1007/s00464-016-4845-6

Labori, K. J., Lassen, K., Hoem, D., Grønbech, J. E., Søreide, J. A., Mortensen, K., Smaaland, R., Sorbye, H., Verbeke, C., & Dueland, S. (2017). Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial. BMC Surg, 17(1), 94. https://doi.org/10.1186/s12893-017-0291-1

Latona, J. A., Lamb, K. M., Pucci, M. J., Maley, W. R., & Yeo, C. J. (2016). Modified Appleby Procedure with Arterial Reconstruction for Locally Advanced Pancreatic Adenocarcinoma: A Literature Review and Report of Three Unusual Cases. J Gastrointest Surg, 20(2), 300-306. https://doi.org/10.1007/s11605-015-3001-2

Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., Wong, F., Azad, N. S., Rucki, A. A., Laheru, D., Donehower, R., Zaheer, A., Fisher, G. A., Crocenzi, T. S., Lee, J. J., Greten, T. F., Duffy, A. G., Ciombor, K. K., Eyring, A. D., Lam, B. H., Joe, A., Kang, S. P., Holdhoff, M., Danilova, L., Cope, L., Meyer, C., Zhou, S., Goldberg, R. M., Armstrong, D. K., Bever, K. M., Fader, A. N., Taube, J., Housseau, F., Spetzler, D., Xiao, N., Pardoll, D. M., Papadopoulos, N., Kinzler, K. W., Eshleman, J. R., Vogelstein, B., Anders, R. A., & Diaz, L. A., Jr. (2017). Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science, 357(6349), 409-413. https://doi.org/10.1126/science.aan6733

Lee, E. S., & Lee, J. M. (2014). Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol, 20(24), 7864-7877. https://doi.org/10.3748/wjg.v20.i24.7864

Lee, K. M., Choi, S. J., Shin, S. J., Hwang, J. C., Lim, S. G., Jung, J. Y., Yoo, B. M., Cho, S. W., & Kim, J. H. (2009). Palliative treatment of malignant gastroduodenal obstruction with metallic stent: prospective comparison of covered and uncovered stents. Scand J Gastroenterol, 44(7), 846-852. https://doi.org/10.1080/00365520902929849

Leppo, J. A. (1995). Preoperative cardiac risk assessment for noncardiac surgery. Am J Cardiol, 75(11), 42d-51d.

Levy, A., Popovici, T., & Bories, P. N. (2017). Tumor markers in pancreatic cystic fluids for diagnosis of malignant cysts. Int J Biol Markers, 32(3), e291-e296. https://doi.org/10.5301/jbm.5000257

Ley, B., Collard, H. R., & King, T. E., Jr. (2011). Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 183(4), 431-440. https://doi.org/10.1164/rccm.201006-0894CI

Li, D., Xie, K., Wolff, R., & Abbruzzese, J. L. (2004). Pancreatic cancer. Lancet, 363(9414), 1049-1057. https://doi.org/10.1016/S0140-6736(04)15841-8

Liang, T. B., Bai, X. L., & Zheng, S. S. (2007). Pancreatic fistula after pancreaticoduodenectomy: diagnosed according to International Study Group Pancreatic Fistula (ISGPF) definition. Pancreatology, 7(4), 325-331. https://doi.org/10.1159/000105498

Lieberman, M. D., Kilburn, H., Lindsey, M., & Brennan, M. F. (1995). Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg, 222(5), 638-645. http://www.ncbi.nlm.nih.gov/pubmed/7487211

Lillemoe, K. D., Cameron, J. L., Hardacre, J. M., Sohn, T. A., Sauter, P. K., Coleman, J., Pitt, H. A., & Yeo, C. J. (1999). Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg, 230(3), 322-328; discussion 328-330. http://www.ncbi.nlm.nih.gov/pubmed/10493479

Lin, P. W., & Lin, Y. J. (1999). Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg, 86(5), 603-607. https://doi.org/10.1046/j.1365-2168.1999.01074.x

Lind, P. A., Isaksson, B., Almstrom, M., Johnsson, A., Albiin, N., Bystrom, P., & Permert, J. (2008). Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma. Acta Oncol, 47(3), 413-420. https://doi.org/10.1080/02841860701592384

Lindkvist, B. (2013). Diagnosis and treatment of pancreatic exocrine insufficiency. World J Gastroenterol, 19(42), 7258-7266. https://doi.org/10.3748/wjg.v19.i42.7258

Lithner, M. a. T. Z. (1998). Does preoperative information increase the wellbeing of the patient after surgery? (in Swedish). Vård i Norden 1998; 18:31-33,39, 1998.

Lohr, J. M., Lonnebro, R., Stigliano, S., Haas, S. L., Swahn, F., Enochsson, L., Noel, R., Segersvard, R., Del Chiaro, M., Verbeke, C. S., & Arnelo, U. (2015). Outcome of probe-based confocal laser endomicroscopy (pCLE) during endoscopic retrograde cholangiopancreatography: A single-center prospective study in 45 patients. United European Gastroenterol J, 3(6), 551-560. https://doi.org/10.1177/2050640615579806

Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R. W., Lankisch, P. G., Andersen, J. R., Dimagno, E. P., Andren-Sandberg, A., & Domellof, L. (1993). Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med, 328(20), 1433-1437. https://doi.org/10.1056/NEJM199305203282001

Lowenfels, A. B., Maisonneuve, P., DiMagno, E. P., Elitsur, Y., Gates, L. K., Jr., Perrault, J., & Whitcomb, D. C. (1997). Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst, 89(6), 442-446. http://www.ncbi.nlm.nih.gov/pubmed/9091646

Lu, X., Wang, X., Fang, Y., Chen, H., Peng, C., Li, H., Deng, X., & Shen, B. (2016). Systematic Review and Meta-Analysis of Pancreatic Amylase Value on Postoperative Day 1 After Pancreatic Resection to Predict Postoperative Pancreatic Fistula. Medicine (Baltimore), 95(5), e2569. https://doi.org/10.1097/MD.0000000000002569

Lu, Y., Garcia Rodriguez, L. A., Malgerud, L., Gonzalez-Perez, A., Martin-Perez, M., Lagergren, J., & Bexelius, T. S. (2015). New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer. Br J Cancer, 113(11), 1607-1614. https://doi.org/10.1038/bjc.2015.353

Lundstrom, S. H., & Furst, C. J. (2006). The use of corticosteroids in Swedish palliative care. Acta Oncol, 45(4), 430-437. https://doi.org/10.1080/02841860500401167

Läkemedelsverket. (2010). Smärtlindring i livets slutskede: ny rekommendation. 2010. Sverige Läkemedelsverket, Smärtlindring i livets slutskede: ny rekommendation 2010, Uppsala: Läkemedelsverket 38 s. 2010;Sverige. Uppsala: Läkemedelsverket. : 38 s.

Löhr, J. M., Beuers, U., Vujasinovic, M., Alvaro, D., Frøkjær, J. B., Buttgereit, F., Capurso, G., Culver, E. L., de-Madaria, E., Della-Torre, E., Detlefsen, S., Dominguez-Muñoz, E., Czubkowski, P., Ewald, N., Frulloni, L., Gubergrits, N., Duman, D. G., Hackert, T., Iglesias-Garcia, J., Kartalis, N., Laghi, A., Lammert, F., Lindgren, F., Okhlobystin, A., Oracz, G., Parniczky, A., Mucelli, R. M. P., Rebours, V., Rosendahl, J., Schleinitz, N., Schneider, A., van Bommel, E. F., Verbeke, C. S., Vullierme, M. P., & Witt, H. (2020). European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. United European Gastroenterol J, 8(6), 637-666. https://doi.org/10.1177/2050640620934911

Ma, S. J., Oladeru, O. T., Miccio, J. A., Iovoli, A. J., Hermann, G. M., & Singh, A. K. (2019). Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer. JAMA Netw Open, 2(8), e199126. https://doi.org/10.1001/jamanetworkopen.2019.9126

Mabrut, J. Y., Fernandez-Cruz, L., Azagra, J. S., Bassi, C., Delvaux, G., Weerts, J., Fabre, J. M., Boulez, J., Baulieux, J., Peix, J. L., Gigot, J. F., Hepatobiliary, Pancreatic Section of the Royal Belgian Society of, S., Belgian Group for Endoscopic, S., & Club, C. (2005). Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients. Surgery, 137(6), 597-605. http://www.ncbi.nlm.nih.gov/pubmed/15962401

Macdonald, G., Kondor, N., Yousefi, V., Green, A., Wong, F., & Aquino-Parsons, C. (2004). Reduction of carboxyhaemoglobin levels in the venous blood of cigarette smokers following the administration of carbogen. Radiother Oncol, 73(3), 367-371. https://doi.org/10.1016/j.radonc.2004.09.002

Maetani, I., Mizumoto, Y., Shigoka, H., Omuta, S., Saito, M., Tokuhisa, J., & Morizane, T. (2014). Placement of a triple-layered covered versus uncovered metallic stent for palliation of malignant gastric outlet obstruction: a multicenter randomized trial. Dig Endosc, 26(2), 192-199. https://doi.org/10.1111/den.12117

Mahgerefteh, S., Hubert, A., Klimov, A., & Bloom, A. I. (2015). Clinical Impact of Percutaneous Transhepatic Insertion of Metal Biliary Endoprostheses for Palliation of Jaundice and Facilitation of Chemotherapy. Am J Clin Oncol, 38(5), 489-494. https://doi.org/10.1097/COC.0b013e3182a5341a

Mahvi, D. (2009). Defining, controlling, and treating a pancreatic fistula. J Gastrointest Surg, 13(7), 1187-1188. https://doi.org/10.1007/s11605-009-0867-x

Maire, F., & Sauvanet, A. (2013). Palliation of biliary and duodenal obstruction in patients with unresectable pancreatic cancer: endoscopy or surgery? J Visc Surg, 150(3 Suppl), S27-31. https://doi.org/10.1016/j.jviscsurg.2013.03.005

Makuc, J. (2016). Management of pancreatogenic diabetes: challenges and solutions. Diabetes Metab Syndr Obes, 9, 311-315. https://doi.org/10.2147/DMSO.S99701

Malekzadeh, F., Rose, C., Ingvar, C., & Jernstrom, H. (2005). [Natural remedies and hormone preparations--potential risk for breast cancer patients. A study surveys the use of agents which possibly counteract with the treatment]. Lakartidningen, 102(44), 3226-3228, 3230-3221. http://www.ncbi.nlm.nih.gov/pubmed/16329453 (Naturlakemedel och hormonpreparat- potentiell risk for brostcancerpatienter. Studie kartlagger bruk av medel som kanske motverkar behandlingen.)

Malvezzi, M., Bertuccio, P., Levi, F., La Vecchia, C., & Negri, E. (2013). European cancer mortality predictions for the year 2013. Ann Oncol, 24(3), 792-800. https://doi.org/10.1093/annonc/mdt010

Manuel-Vázquez, A., Latorre-Fragua, R., Ramiro-Pérez, C., López-Marcano, A., la Plaza-Llamas, R., & Ramia, J. M. (2018). Laparoscopic gastrojejunostomy for gastric outlet obstruction in patients with unresectable hepatopancreatobiliary cancers: A personal series and systematic review of the literature. World J Gastroenterol, 24(18), 1978-1988. https://doi.org/10.3748/wjg.v24.i18.1978

Markar, S. R., Vyas, S., Karthikesalingam, A., Imber, C., & Malago, M. (2012). The impact of pancreatic duct drainage following pancreaticojejunostomy on clinical outcome. J Gastrointest Surg, 16(8), 1610-1617. https://doi.org/10.1007/s11605-012-1852-3

Markov, P., Satoi, S., & Kon, M. (2016). Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci, 23(9), 523-532. https://doi.org/10.1002/jhbp.374

Matsuoka, L., Selby, R., & Genyk, Y. (2012). The surgical management of pancreatic cancer. Gastroenterol Clin North Am, 41(1), 211-221. https://doi.org/10.1016/j.gtc.2011.12.015

Matthaei, H., Norris, A. L., Tsiatis, A. C., Olino, K., Hong, S. M., dal Molin, M., Goggins, M. G., Canto, M., Horton, K. M., Jackson, K. D., Capelli, P., Zamboni, G., Bortesi, L., Furukawa, T., Egawa, S., Ishida, M., Ottomo, S., Unno, M., Motoi, F., Wolfgang, C. L., Edil, B. H., Cameron, J. L., Eshleman, J. R., Schulick, R. D., Maitra, A., & Hruban, R. H. (2012). Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg, 255(2), 326-333. https://doi.org/10.1097/SLA.0b013e3182378a18

Mazzeo, S., Cappelli, C., Battaglia, V., Caramella, D., Caproni, G., Pontillo Contillo, B., Del Chiaro, M., Boggi, U., Funel, N., Pollina, L., Campani, D., Mosca, F., & Bartolozzi, C. (2010). Multidetector CT in the evaluation of retroperitoneal fat tissue infiltration in ductal adenocarcinoma of the pancreatic head: correlation with histopathological findings. Abdom Imaging, 35(4), 465-470. https://doi.org/10.1007/s00261-009-9548-1

Mazzeo, S., Cappelli, C., Caramella, D., Del Chiaro, M., Campani, D., Pollina, L., Caproni, G., Battaglia, V., Belcari, A., Funel, N., Di Candio, G., Forasassi, F., Boggi, U., Bevilacqua, G., Mosca, F., & Bartolozzi, C. (2007). Evaluation of vascular infiltration in resected patients for pancreatic cancer: comparison among multidetector CT, intraoperative findings and histopathology. Abdom Imaging, 32(6), 737-742. https://doi.org/10.1007/s00261-006-9172-2

McClave, S. A., Kozar, R., Martindale, R. G., Heyland, D. K., Braga, M., Carli, F., Drover, J. W., Flum, D., Gramlich, L., Herndon, D. N., Ko, C., Kudsk, K. A., Lawson, C. M., Miller, K. R., Taylor, B., & Wischmeyer, P. E. (2013). Summary points and consensus recommendations from the North American Surgical Nutrition Summit. JPEN J Parenter Enteral Nutr, 37(5 Suppl), 99S-105S. https://doi.org/10.1177/0148607113495892

McWilliams, R. R., Maisonneuve, P., Bamlet, W. R., Petersen, G. M., Li, D., Risch, H. A., Yu, H., Fontham, E. T., Luckett, B., Bosetti, C., Negri, E., La Vecchia, C., Talamini, R., Bueno de Mesquita, H. B., Bracci, P., Gallinger, S., Neale, R. E., & Lowenfels, A. B. (2016). Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis. Pancreas, 45(2), 311-316. https://doi.org/10.1097/MPA.0000000000000392

Menon, K. V., Gomez, D., Smith, A. M., Anthoney, A., & Verbeke, C. S. (2009). Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB (Oxford), 11(1), 18-24. https://doi.org/10.1111/j.1477-2574.2008.00013.x

Mercadante, S., Catala, E., Arcuri, E., & Casuccio, A. (2003). Celiac plexus block for pancreatic cancer pain: factors influencing pain, symptoms and quality of life. J Pain Symptom Manage, 26(6), 1140-1147. http://www.ncbi.nlm.nih.gov/pubmed/14654266

Mercadante, S., Tirelli, W., David, F., Arcara, C., Fulfaro, F., Casuccio, A., & Gebbia, V. (2010). Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. Clin J Pain, 26(9), 794-797. http://www.ncbi.nlm.nih.gov/pubmed/20973155

Meyskens, F. L., Jr., Mukhtar, H., Rock, C. L., Cuzick, J., Kensler, T. W., Yang, C. S., Ramsey, S. D., Lippman, S. M., & Alberts, D. S. (2016). Cancer Prevention: Obstacles, Challenges and the Road Ahead. J Natl Cancer Inst, 108(2). https://doi.org/10.1093/jnci/djv309

Micames, C., Jowell, P. S., White, R., Paulson, E., Nelson, R., Morse, M., Hurwitz, H., Pappas, T., Tyler, D., & McGrath, K. (2003). Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc, 58(5), 690-695. http://www.ncbi.nlm.nih.gov/pubmed/14595302

Michalski, C. W., Erkan, M., Huser, N., Muller, M. W., Hartel, M., Friess, H., & Kleeff, J. (2008). Resection of primary pancreatic cancer and liver metastasis: a systematic review. Dig Surg, 25(6), 473-480. https://doi.org/10.1159/000184739

Michalski, C. W., Kleeff, J., Wente, M. N., Diener, M. K., Buchler, M. W., & Friess, H. (2007). Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg, 94(3), 265-273. https://doi.org/10.1002/bjs.5716

Micke, O., Bruns, F., Schafer, U., Kurowski, R., Horst, E., & Willich, N. (2003). CA 19-9 in the therapy monitoring and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy. Anticancer Res, 23(2A), 835-840. http://www.ncbi.nlm.nih.gov/pubmed/12820309

Mintziras, I., & Bartsch, D. K. (2019). Progress report: familial pancreatic cancer. Fam Cancer, 18(3), 359-362. https://doi.org/10.1007/s10689-019-00125-9

Miyazaki, M., Yoshitomi, H., Shimizu, H., Ohtsuka, M., Yoshidome, H., Furukawa, K., Takayasiki, T., Kuboki, S., Okamura, D., Suzuki, D., & Nakajima, M. (2014). Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile? Surgery, 155(1), 58-66. https://doi.org/10.1016/j.surg.2013.06.050

Modha, K. (2015). Clinical Approach to Patients With Obstructive Jaundice. Tech Vasc Interv Radiol, 18(4), 197-200. https://doi.org/10.1053/j.tvir.2015.07.002

Mollberg, N., Rahbari, N. N., Koch, M., Hartwig, W., Hoeger, Y., Buchler, M. W., & Weitz, J. (2011). Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg, 254(6), 882-893. https://doi.org/10.1097/SLA.0b013e31823ac299

Moole, H., Bechtold, M. L., Cashman, M., Volmar, F. H., Dhillon, S., Forcione, D., Taneja, D., & Puli, S. R. (2016). Covered versus uncovered self-expandable metal stents for malignant biliary strictures: A meta-analysis and systematic review. Indian J Gastroenterol, 35(5), 323-330. https://doi.org/10.1007/s12664-016-0682-8

Moore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., Campos, D., Lim, R., Ding, K., Clark, G., Voskoglou-Nomikos, T., Ptasynski, M., & Parulekar, W. (2007). Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol, 25(15), 1960-1966. https://doi.org/10.1200/jco.2006.07.9525

Morgan, K. A., Lancaster, W. P., Walters, M. L., Owczarski, S. M., Clark, C. A., McSwain, J. R., & Adams, D. B. (2016). Enhanced Recovery After Surgery Protocols Are Valuable in Pancreas Surgery Patients. J Am Coll Surg, 222(4), 658-664. https://doi.org/10.1016/j.jamcollsurg.2015.12.036

Morrison, M. (2010). Post-pancreatic resection: general overview and unique complications. Dimensions of Critical Care Nursing, 29(4), 157-162.

Moss, A. C., Morris, E., & Mac Mathuna, P. (2006). Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst Rev(1), CD004200. https://doi.org/10.1002/14651858.CD004200.pub2

Moss. (2010). Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane review 2010; 2010:11.

Motosugi, U., Ichikawa, T., Morisaka, H., Sou, H., Muhi, A., Kimura, K., Sano, K., & Araki, T. (2011). Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology, 260(2), 446-453. https://doi.org/10.1148/radiol.11103548

Mueller, T. C., Burmeister, M. A., Bachmann, J., & Martignoni, M. E. (2014). Cachexia and pancreatic cancer: are there treatment options? World J Gastroenterol, 20(28), 9361-9373. https://doi.org/10.3748/wjg.v20.i28.9361

Mullen, J. T., Lee, J. H., Gomez, H. F., Ross, W. A., Fukami, N., Wolff, R. A., Abdalla, E. K., Vauthey, J. N., Lee, J. E., Pisters, P. W., & Evans, D. B. (2005). Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg, 9(8), 1094-1104; discussion 1104-1095. https://doi.org/10.1016/j.gassur.2005.08.006

Muller, M. W., Friess, H., Koninger, J., Martin, D., Wente, M. N., Hinz, U., Ceyhan, G. O., Blaha, P., Kleeff, J., & Buchler, M. W. (2008). Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas. Am J Surg, 195(2), 221-228. https://doi.org/10.1016/j.amjsurg.2007.02.026

Muller, S. A., Hartel, M., Mehrabi, A., Welsch, T., Martin, D. J., Hinz, U., Schmied, B. M., & Buchler, M. W. (2009). Vascular resection in pancreatic cancer surgery: survival determinants. J Gastrointest Surg, 13(4), 784-792. https://doi.org/10.1007/s11605-008-0791-5

Munshi, M. N., Florez, H., Huang, E. S., Kalyani, R. R., Mupanomunda, M., Pandya, N., Swift, C. S., Taveira, T. H., & Haas, L. B. (2016). Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association. Diabetes Care, 39(2), 308-318. https://doi.org/10.2337/dc15-2512

Muscari, F., Suc, B., Kirzin, S., Hay, J. M., Fourtanier, G., Fingerhut, A., Sastre, B., Chipponi, J., Fagniez, P. L., Radovanovic, A., & French Associations for Surgical, R. (2006). Risk factors for mortality and intra-abdominal complications after pancreatoduodenectomy: multivariate analysis in 300 patients. Surgery, 139(5), 591-598. https://doi.org/10.1016/j.surg.2005.08.012

Nagashio, Y., Hijioka, S., Mizuno, N., Hara, K., Imaoka, H., Bhatia, V., Niwa, Y., Tajika, M., Tanaka, T., Ishihara, M., Shimizu, Y., Hosoda, W., Yatabe, Y., & Yamao, K. (2014). Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms. Pancreatology, 14(6), 503-509. https://doi.org/10.1016/j.pan.2014.09.011

Nakamura, T., Hirano, S., Noji, T., Asano, T., Okamura, K., Tsuchikawa, T., Murakami, S., Kurashima, Y., Ebihara, Y., Nakanishi, Y., Tanaka, K., & Shichinohe, T. (2016). Distal Pancreatectomy with en Bloc Celiac Axis Resection (Modified Appleby Procedure) for Locally Advanced Pancreatic Body Cancer: A Single-Center Review of 80 Consecutive Patients. Ann Surg Oncol, 23(Suppl 5), 969-975. https://doi.org/10.1245/s10434-016-5493-8

Nakao, A., Kanzaki, A., Fujii, T., Kodera, Y., Yamada, S., Sugimoto, H., Nomoto, S., Nakamura, S., Morita, S., & Takeda, S. (2012). Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer. Ann Surg, 255(1), 103-108. https://doi.org/10.1097/SLA.0b013e318237872e

Nakao, A., Takeda, S., Inoue, S., Nomoto, S., Kanazumi, N., Sugimoto, H., & Fujii, T. (2006). Indications and techniques of extended resection for pancreatic cancer. World J Surg, 30(6), 976-982; discussion 983-974. https://doi.org/10.1007/s00268-005-0438-6

Nakayama, Y., Yamashita, Y., Kadota, M., Takahashi, M., Kanemitsu, K., Hiraoka, T., Hirota, M., Ogawa, M., & Takeya, M. (2001). Vascular encasement by pancreatic cancer: correlation of CT findings with surgical and pathologic results. J Comput Assist Tomogr, 25(3), 337-342. http://www.ncbi.nlm.nih.gov/pubmed/11351180

Nath, B., Li, Y., Carroll, J. E., Szabo, G., Tseng, J. F., & Shah, S. A. (2010). Alcohol exposure as a risk factor for adverse outcomes in elective surgery. J Gastrointest Surg, 14(11), 1732-1741. https://doi.org/10.1007/s11605-010-1350-4

National Comprehensive Cancer Network (NCCN). Pancreatic adenocarcinoma, NCCN guidelines. https://www.nccn.org/professionals/physician_gls/default.aspx#site

National comrehensive cancer network Clinical Practice Guidelines in Oncology. (2020a). Genetic Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, version 1.2020. https://www.nccn.org/professionals/physician_gls/default.aspx

National comrehensive cancer network Clinical Practice Guidelines in Oncology. (2020b). Pancreatic Adenocarcinoma version 1.2020. www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf

Neoptolemos, J. P., Dunn, J. A., Stocken, D. D., Almond, J., Link, K., Beger, H., Bassi, C., Falconi, M., Pederzoli, P., Dervenis, C., Fernandez-Cruz, L., Lacaine, F., Pap, A., Spooner, D., Kerr, D. J., Friess, H., Buchler, M. W., & European Study Group for Pancreatic, C. (2001). Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet, 358(9293), 1576-1585. http://www.ncbi.nlm.nih.gov/pubmed/11716884

Neoptolemos, J. P., Moore, M. J., Cox, T. F., Valle, J. W., Palmer, D. H., McDonald, A. C., Carter, R., Tebbutt, N. C., Dervenis, C., Smith, D., Glimelius, B., Charnley, R. M., Lacaine, F., Scarfe, A. G., Middleton, M. R., Anthoney, A., Ghaneh, P., Halloran, C. M., Lerch, M. M., Olah, A., Rawcliffe, C. L., Verbeke, C. S., Campbell, F., Buchler, M. W., & European Study Group for Pancreatic, C. (2012). Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA, 308(2), 147-156. https://doi.org/10.1001/jama.2012.7352

Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Psarelli, E. E., Valle, J. W., Halloran, C. M., Faluyi, O., O'Reilly, D. A., Cunningham, D., Wadsley, J., Darby, S., Meyer, T., Gillmore, R., Anthoney, A., Lind, P., Glimelius, B., Falk, S., Izbicki, J. R., Middleton, G. W., Cummins, S., Ross, P. J., Wasan, H., McDonald, A., Crosby, T., Ma, Y. T., Patel, K., Sherriff, D., Soomal, R., Borg, D., Sothi, S., Hammel, P., Hackert, T., Jackson, R., Buchler, M. W., & European Study Group for Pancreatic, C. (2017). Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet, 389(10073), 1011-1024. https://doi.org/10.1016/S0140-6736(16)32409-6

Neoptolemos, J. P., Stocken, D. D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., Padbury, R., Moore, M. J., Gallinger, S., Mariette, C., Wente, M. N., Izbicki, J. R., Friess, H., Lerch, M. M., Dervenis, C., Oláh, A., Butturini, G., Doi, R., Lind, P. A., Smith, D., Valle, J. W., Palmer, D. H., Buckels, J. A., Thompson, J., McKay, C. J., Rawcliffe, C. L., & Büchler, M. W. (2010). Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA, 304(10), 1073-1081. https://doi.org/10.1001/jama.2010.1275

NHS. (2001). Guidance on commissioning cancer services. Improving the outcomes in upper gastro-intestinal cancers. NHS Executive2001.

Nicholson, A. B. (2007). Methadone for cancer pain. Cochrane Database Syst Rev(4), Cd003971. https://doi.org/10.1002/14651858.CD003971.pub3

Nimura, Y., Nagino, M., Takao, S., Takada, T., Miyazaki, K., Kawarada, Y., Miyagawa, S., Yamaguchi, A., Ishiyama, S., Takeda, Y., Sakoda, K., Kinoshita, T., Yasui, K., Shimada, H., & Katoh, H. (2012). Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci, 19(3), 230-241. https://doi.org/10.1007/s00534-011-0466-6

Nordback, I., Saaristo, R., Piironen, A., & Sand, J. (2004). Chest computed tomography in the staging of pancreatic and periampullary carcinoma. Scand J Gastroenterol, 39(1), 81-86. http://www.ncbi.nlm.nih.gov/pubmed/14992566

Oberg, K. (2011). Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer, 18 Suppl 1, S17-25. https://doi.org/10.1530/ERC-10-0280

Oettle, H., Riess, H., Stieler, J. M., Heil, G., Schwaner, I., Seraphin, J., Görner, M., Mölle, M., Greten, T. F., Lakner, V., Bischoff, S., Sinn, M., Dörken, B., & Pelzer, U. (2014). Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial. J Clin Oncol, 32(23), 2423-2429. https://doi.org/10.1200/jco.2013.53.6995

Oh, S. H., Lee, J. K., Lee, K. T., Lee, K. H., Woo, Y. S., & Noh, D. H. (2017). The Combination of Cyst Fluid Carcinoembryonic Antigen, Cytology and Viscosity Increases the Diagnostic Accuracy of Mucinous Pancreatic Cysts. Gut Liver, 11(2), 283-289. https://doi.org/10.5009/gnl15650

Ong, S. L., Garcea, G., Pollard, C. A., Furness, P. N., Steward, W. P., Rajesh, A., Spencer, L., Lloyd, D. M., Berry, D. P., & Dennison, A. R. (2009). A fuller understanding of pancreatic neuroendocrine tumours combined with aggressive management improves outcome. Pancreatology, 9(5), 583-600. https://doi.org/10.1159/000212085

Palanivelu, C., Senthilnathan, P., Sabnis, S. C., Babu, N. S., Srivatsan Gurumurthy, S., Anand Vijai, N., Nalankilli, V. P., Praveen Raj, P., Parthasarathy, R., & Rajapandian, S. (2017). Randomized clinical trial of laparoscopic versus open pancreatoduodenectomy for periampullary tumours. Br J Surg, 104(11), 1443-1450. https://doi.org/10.1002/bjs.10662

Pandé, R., Hodson, J., Murray, A., Marcon, F., Kalisvaart, M., Marudanayagam, R., Sutcliffe, R. P., Mirza, D. F., Isaac, J., & Roberts, K. J. (2019). Evaluation of the clinical and economic impact of delays to surgery in patients with periampullary cancer. BJS Open, 3(4), 476-484. https://doi.org/10.1002/bjs5.50161

Pannala, R., Leirness, J. B., Bamlet, W. R., Basu, A., Petersen, G. M., & Chari, S. T. (2008). Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology, 134(4), 981-987. https://doi.org/10.1053/j.gastro.2008.01.039

Passeri, M. J., Baker, E. H., Siddiqui, I. A., Templin, M. A., Martinie, J. B., Vrochides, D., & Iannitti, D. A. (2019). Total compared with partial pancreatectomy for pancreatic adenocarcinoma: assessment of resection margin, readmission rate, and survival from the U.S. National Cancer Database. Curr Oncol, 26(3), e346-e356. https://doi.org/10.3747/co.26.4066

Pavlidis, T. E., Pavlidis, E. T., & Sakantamis, A. K. (2011). Current opinion on lymphadenectomy in pancreatic cancer surgery. Hepatobiliary Pancreat Dis Int, 10(1), 21-25. http://www.ncbi.nlm.nih.gov/pubmed/21269930

Pawlik, T. M., Gleisner, A. L., Cameron, J. L., Winter, J. M., Assumpcao, L., Lillemoe, K. D., Wolfgang, C., Hruban, R. H., Schulick, R. D., Yeo, C. J., & Choti, M. A. (2007). Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery, 141(5), 610-618. https://doi.org/10.1016/j.surg.2006.12.013

Pea, A., Yu, J., Rezaee, N., Luchini, C., He, J., Dal Molin, M., Griffin, J. F., Fedor, H., Fesharakizadeh, S., Salvia, R., Weiss, M. J., Bassi, C., Cameron, J. L., Zheng, L., Scarpa, A., Hruban, R. H., Lennon, A. M., Goggins, M., Wolfgang, C. L., & Wood, L. D. (2016). Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas. Ann Surg. https://doi.org/10.1097/SLA.0000000000001817

Pecorelli, N., Carrara, G., De Cobelli, F., Cristel, G., Damascelli, A., Balzano, G., Beretta, L., & Braga, M. (2016). Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. Br J Surg, 103(4), 434-442. https://doi.org/10.1002/bjs.10063

Pedrazzoli, S., Beger, H. G., Obertop, H., Andren-Sandberg, A., Fernandez-Cruz, L., Henne-Bruns, D., Luttges, J., & Neoptolemos, J. P. (1999). A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg, 16(4), 337-345. https://doi.org/18744

Peng, S. Y., Wang, J. W., Lau, W. Y., Cai, X. J., Mou, Y. P., Liu, Y. B., & Li, J. T. (2007). Conventional versus binding pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg, 245(5), 692-698. https://doi.org/10.1097/01.sla.0000255588.50964.5d

Perez-Miranda, M., Tyberg, A., Poletto, D., Toscano, E., Gaidhane, M., Desai, A. P., Kumta, N. A., Fayad, L., Nieto, J., Barthet, M., Shah, R., Brauer, B. C., Sharaiha, R. Z., & Kahaleh, M. (2017). EUS-guided Gastrojejunostomy Versus Laparoscopic Gastrojejunostomy: An International Collaborative Study. J Clin Gastroenterol, 51(10), 896-899. https://doi.org/10.1097/mcg.0000000000000887

Perone, J. A., Riall, T. S., & Olino, K. (2016). Palliative Care for Pancreatic and Periampullary Cancer. Surg Clin North Am, 96(6), 1415-1430. https://doi.org/10.1016/j.suc.2016.07.012

Peterson, C. (2005). [Natural remedies--self care at your own risk! Danger of unknown adverse effects and interactions with "common" medications]. Lakartidningen, 102(44), 3200-3201. http://www.ncbi.nlm.nih.gov/pubmed/16329448 (Naturlakemedel--egenvard pa egen risk! Fara for okanda biverkningar och interaktioner med "vanliga" lakemedel.)

Pietryga, J. A., & Morgan, D. E. (2015). Imaging preoperatively for pancreatic adenocarcinoma. J Gastrointest Oncol, 6(4), 343-357. https://doi.org/10.3978/j.issn.2078-6891.2015.024

Pittman, M. E., Brosens, L. A., & Wood, L. D. (2016). Genetic Syndromes with Pancreatic Manifestations. Surg Pathol Clin, 9(4), 705-715. https://doi.org/10.1016/j.path.2016.05.012

Porembka, M. R., Hawkins, W. G., Linehan, D. C., Gao, F., Ma, C., Brunt, E. M., & Strasberg, S. M. (2011). Radiologic and intraoperative detection of need for mesenteric vein resection in patients with adenocarcinoma of the head of the pancreas. HPB (Oxford), 13(9), 633-642. https://doi.org/10.1111/j.1477-2574.2011.00343.x

Potz, B. A., & Miner, T. J. (2016). Surgical palliation of gastric outlet obstruction in advanced malignancy. World J Gastrointest Surg, 8(8), 545-555. https://doi.org/10.4240/wjgs.v8.i8.545

Poves, I., Burdío, F., Morató, O., Iglesias, M., Radosevic, A., Ilzarbe, L., Visa, L., & Grande, L. (2018). Comparison of Perioperative Outcomes Between Laparoscopic and Open Approach for Pancreatoduodenectomy: The PADULAP Randomized Controlled Trial. Ann Surg, 268(5), 731-739. https://doi.org/10.1097/sla.0000000000002893

Prenzel, K. L., Holscher, A. H., Vallbohmer, D., Drebber, U., Gutschow, C. A., Monig, S. P., & Stippel, D. L. (2010). Lymph node size and metastatic infiltration in adenocarcinoma of the pancreatic head. Eur J Surg Oncol, 36(10), 993-996. https://doi.org/10.1016/j.ejso.2010.06.009

Probst, P., Huttner, F. J., Klaiber, U., Knebel, P., Ulrich, A., Buchler, M. W., & Diener, M. K. (2015). Stapler versus scalpel resection followed by hand-sewn closure of the pancreatic remnant for distal pancreatectomy. Cochrane Database Syst Rev(11), CD008688. https://doi.org/10.1002/14651858.CD008688.pub2

Prochazka, M., Granath, F., Ekbom, A., Shields, P. G., & Hall, P. (2002). Lung cancer risks in women with previous breast cancer. Eur J Cancer, 38(11), 1520-1525. http://www.ncbi.nlm.nih.gov/pubmed/12110499

Prokesch, R. W., Chow, L. C., Beaulieu, C. F., Bammer, R., & Jeffrey, R. B., Jr. (2002). Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology, 224(3), 764-768. https://doi.org/10.1148/radiol.2243011284

Puli, S. R., Bechtold, M. L., Buxbaum, J. L., & Eloubeidi, M. A. (2013). How good is endoscopic ultrasound-guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass?: A meta-analysis and systematic review. Pancreas, 42(1), 20-26. https://doi.org/10.1097/MPA.0b013e3182546e79

Qian, D., Lu, Z., Jackson, R., Wu, J., Liu, X., Cai, B., Wu, P., Yin, J., Xu, Q., Xu, D., Peng, Y., Jiang, K., & Miao, Y. (2016). Effect of antecolic or retrocolic route of gastroenteric anastomosis on delayed gastric emptying after pancreaticoduodenectomy: A meta-analysis of randomized controlled trials. Pancreatology, 16(1), 142-150. https://doi.org/10.1016/j.pan.2015.11.003

Que, W., Fang, H., Yan, B., Li, J., Guo, W., Zhai, W., & Zhang, S. (2015). Pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials. Am J Surg, 209(6), 1074-1082. https://doi.org/10.1016/j.amjsurg.2014.07.019

Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J. F., Flaherty, K. R., Lasky, J. A., Lynch, D. A., Ryu, J. H., Swigris, J. J., Wells, A. U., Ancochea, J., Bouros, D., Carvalho, C., Costabel, U., Ebina, M., Hansell, D. M., Johkoh, T., Kim, D. S., King, T. E., Jr., Kondoh, Y., Myers, J., Müller, N. L., Nicholson, A. G., Richeldi, L., Selman, M., Dudden, R. F., Griss, B. S., Protzko, S. L., & Schünemann, H. J. (2011). An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med, 183(6), 788-824. https://doi.org/10.1164/rccm.2009-040GL

Rahma, O. E., Duffy, A., Liewehr, D. J., Steinberg, S. M., & Greten, T. F. (2013). Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trials. Ann Oncol, 24(8), 1972-1979. https://doi.org/10.1093/annonc/mdt166

Raimondi, S., Lowenfels, A. B., Morselli-Labate, A. M., Maisonneuve, P., & Pezzilli, R. (2010). Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol, 24(3), 349-358. https://doi.org/10.1016/j.bpg.2010.02.007

Raimondi, S., Maisonneuve, P., Lohr, J. M., & Lowenfels, A. B. (2007). Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors. Cancer Epidemiol Biomarkers Prev, 16(9), 1894-1897. https://doi.org/10.1158/1055-9965.EPI-07-0341

Raman, S. P., Horton, K. M., & Fishman, E. K. (2012). Multimodality imaging of pancreatic cancer-computed tomography, magnetic resonance imaging, and positron emission tomography. Cancer J, 18(6), 511-522. https://doi.org/10.1097/PPO.0b013e318274a461

Ravikumar, R., Sabin, C., Abu Hilal, M., Bramhall, S., White, S., Wigmore, S., Imber, C. J., Fusai, G., & Group, U. K. V. R. i. P. C. S. (2014). Portal vein resection in borderline resectable pancreatic cancer: a United Kingdom multicenter study. J Am Coll Surg, 218(3), 401-411. https://doi.org/10.1016/j.jamcollsurg.2013.11.017

Reilly, D. F., McNeely, M. J., Doerner, D., Greenberg, D. L., Staiger, T. O., Geist, M. J., Vedovatti, P. A., Coffey, J. E., Mora, M. W., Johnson, T. R., Guray, E. D., Van Norman, G. A., & Fihn, S. D. (1999). Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med, 159(18), 2185-2192. http://www.ncbi.nlm.nih.gov/pubmed/10527296

Riall, T. S., Eschbach, K. A., Townsend, C. M., Jr., Nealon, W. H., Freeman, J. L., & Goodwin, J. S. (2007). Trends and disparities in regionalization of pancreatic resection. J Gastrointest Surg, 11(10), 1242-1251; discussion 1251-1242. https://doi.org/10.1007/s11605-007-0245-5

Riall, T. S., Nealon, W. H., Goodwin, J. S., Townsend, C. M., Jr., & Freeman, J. L. (2008). Outcomes following pancreatic resection: variability among high-volume providers. Surgery, 144(2), 133-140. https://doi.org/10.1016/j.surg.2008.03.041

Rindi, G., Kloppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., Korner, M., Lopes, J. M., McNicol, A. M., Nilsson, O., Perren, A., Scarpa, A., Scoazec, J. Y., Wiedenmann, B., all other Frascati Consensus Conference, p., & European Neuroendocrine Tumor, S. (2006). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch, 449(4), 395-401. https://doi.org/10.1007/s00428-006-0250-1

Ripamonti, C. I., Easson, A. M., & Gerdes, H. (2008). Management of malignant bowel obstruction. Eur J Cancer, 44(8), 1105-1115. https://doi.org/10.1016/j.ejca.2008.02.028

Riviere, D., Gurusamy, K. S., Kooby, D. A., Vollmer, C. M., Besselink, M. G., Davidson, B. R., & van Laarhoven, C. J. (2016). Laparoscopic versus open distal pancreatectomy for pancreatic cancer. Cochrane Database Syst Rev, 4, CD011391. https://doi.org/10.1002/14651858.CD011391.pub2

Roberts, K. J., Schrem, H., Hodson, J., Angelico, R., Dasari, B. V. M., Coldham, C. A., Marudanayagam, R., Sutcliffe, R. P., Muiesan, P., Isaac, J., & Mirza, D. F. (2017). Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy. HPB (Oxford), 19(10), 859-867. https://doi.org/10.1016/j.hpb.2017.05.009

Roulin, D., Cerantola, Y., Demartines, N., & Schafer, M. (2011). Systematic review of delayed postoperative hemorrhage after pancreatic resection. J Gastrointest Surg, 15(6), 1055-1062. https://doi.org/10.1007/s11605-011-1427-8

Rulyak, S. J., Lowenfels, A. B., Maisonneuve, P., & Brentnall, T. A. (2003). Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology, 124(5), 1292-1299. http://www.ncbi.nlm.nih.gov/pubmed/12730869

Sabater, L., Ausania, F., Bakker, O. J., Boadas, J., Dominguez-Munoz, J. E., Falconi, M., Fernandez-Cruz, L., Frulloni, L., Gonzalez-Sanchez, V., Larino-Noia, J., Lindkvist, B., Lluis, F., Morera-Ocon, F., Martin-Perez, E., Marra-Lopez, C., Moya-Herraiz, A., Neoptolemos, J. P., Pascual, I., Perez-Aisa, A., Pezzilli, R., Ramia, J. M., Sanchez, B., Molero, X., Ruiz-Montesinos, I., Vaquero, E. C., & de-Madaria, E. (2016). Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pancreatic Surgery. Ann Surg, 264(6), 949-958. https://doi.org/10.1097/SLA.0000000000001732

Sakaguchi, T., Valente, R., Tanaka, K., Satoi, S., & Del Chiaro, M. (2019). Surgical treatment of metastatic pancreatic ductal adenocarcinoma: A review of current literature. Pancreatology, 19(5), 672-680. https://doi.org/10.1016/j.pan.2019.05.466

Sanjeevi, S., Ivanics, T., Lundell, L., Kartalis, N., Andrén-Sandberg, Å., Blomberg, J., Del Chiaro, M., & Ansorge, C. (2016). Impact of delay between imaging and treatment in patients with potentially curable pancreatic cancer. Br J Surg, 103(3), 267-275. https://doi.org/10.1002/bjs.10046

Santangelo, M., Esposito, A., Tammaro, V., Calogero, A., Criscitiello, C., Roberti, G., Candida, M., Rupealta, N., Pisani, A., & Carlomagno, N. (2016). What indication, morbidity and mortality for central pancreatectomy in oncological surgery? A systematic review. Int J Surg, 28 Suppl 1, S172-176. https://doi.org/10.1016/j.ijsu.2015.12.046

Sasaki, T., Isayama, H., Nakai, Y., Togawa, O., Kogure, H., Kawakubo, K., Mizuno, S., Yashima, Y., Ito, Y., Yamamoto, N., Sasahira, N., Hirano, K., Tsujino, T., Toda, N., Tada, M., Omata, M., & Koike, K. (2012). Predictive factors of solid food intake in patients with malignant gastric outlet obstruction receiving self-expandable metallic stents for palliation. Dig Endosc, 24(4), 226-230. https://doi.org/10.1111/j.1443-1661.2011.01208.x

Sasson, A. R., Hoffman, J. P., Ross, E. A., Kagan, S. A., Pingpank, J. F., & Eisenberg, B. L. (2002). En bloc resection for locally advanced cancer of the pancreas: is it worthwhile? J Gastrointest Surg, 6(2), 147-157; discussion 157-148. http://www.ncbi.nlm.nih.gov/pubmed/11992799

Satoi, S., Fujii, T., Yanagimoto, H., Motoi, F., Kurata, M., Takahara, N., Yamada, S., Yamamoto, T., Mizuma, M., Honda, G., Isayama, H., Unno, M., Kodera, Y., Ishigami, H., & Kon, M. (2017). Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis. Ann Surg, 265(2), 397-401. https://doi.org/10.1097/sla.0000000000001705

Sawai, Y., Yamao, K., Bhatia, V., Chiba, T., Mizuno, N., Sawaki, A., Takahashi, K., Tajika, M., Shimizu, Y., Yatabe, Y., & Yanagisawa, A. (2010). Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Endoscopy, 42(12), 1077-1084. https://doi.org/10.1055/s-0030-1255971

Schima, W., Ba-Ssalamah, A., Kolblinger, C., Kulinna-Cosentini, C., Puespoek, A., & Gotzinger, P. (2007). Pancreatic adenocarcinoma. Eur Radiol, 17(3), 638-649. https://doi.org/10.1007/s00330-006-0435-7

Schmidt, C. M., Turrini, O., Parikh, P., House, M. G., Zyromski, N. J., Nakeeb, A., Howard, T. J., Pitt, H. A., & Lillemoe, K. D. (2010). Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience. Arch Surg, 145(7), 634-640. https://doi.org/10.1001/archsurg.2010.118

Scholten, L., Stoop, T. F., Del Chiaro, M., Busch, O. R., van Eijck, C., Molenaar, I. Q., de Vries, J. H., & Besselink, M. G. (2019). Systematic review of functional outcome and quality of life after total pancreatectomy. Br J Surg, 106(13), 1735-1746. https://doi.org/10.1002/bjs.11296

Scott, I. A., Shohag, H. A., Kam, P. C., Jelinek, M. V., & Khadem, G. M. (2013). Preoperative cardiac evaluation and management of patients undergoing elective non-cardiac surgery. Med J Aust, 199(10), 667-673. http://www.ncbi.nlm.nih.gov/pubmed/24237096

Seelig, M. H., Janot, M., Chromik, A. M., Herzog, T., Belyaev, O., Weyhe, D., Meurer, K., Meiser, A., Tannapfel, A., & Uhl, W. (2009). Redo-surgery following curative resection of pancreatic carcinoma: the difference between true and suspected recurrence. Dig Surg, 26(3), 222-228. https://doi.org/10.1159/000219332

Seiler, C. M., Izbicki, J., Varga-Szabo, L., Czako, L., Fiok, J., Sperti, C., Lerch, M. M., Pezzilli, R., Vasileva, G., Pap, A., Varga, M., & Friess, H. (2013). Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension. Aliment Pharmacol Ther, 37(7), 691-702. https://doi.org/10.1111/apt.12236

Shah. (2018). Essentials of Clinical Pulmonology [Elektronisk resurs]. CRC Press.

Sharp, L., Johansson, H., Hatschek, T., & Bergenmar, M. (2013). Smoking as an independent risk factor for severe skin reactions due to adjuvant radiotherapy for breast cancer. Breast, 22(5), 634-638. https://doi.org/10.1016/j.breast.2013.07.047

Shima, Y., Okabayashi, T., Kozuki, A., Sumiyoshi, T., Tokumaru, T., Saisaka, Y., Date, K., & Iwata, J. (2015). Completion pancreatectomy for recurrent pancreatic cancer in the remnant pancreas: report of six cases and a review of the literature. Langenbecks Arch Surg, 400(8), 973-978. https://doi.org/10.1007/s00423-015-1355-2

Shimoda, M., Katoh, M., Yukihiro, I., Kita, J., Sawada, T., & Kubota, K. (2012). Body mass index is a risk factor of pancreatic fistula after pancreaticoduodenectomy. Am Surg, 78(2), 190-194. http://www.ncbi.nlm.nih.gov/pubmed/22369828

Shimoike, N., Fujikawa, T., Maekawa, H., & Tanaka, A. (2013). Aggressive secondary surgery for local recurrence of pancreatic cancer. BMJ Case Rep, 2013. https://doi.org/10.1136/bcr-2013-009914

Shimosegawa, T., Chari, S. T., Frulloni, L., Kamisawa, T., Kawa, S., Mino-Kenudson, M., Kim, M. H., Klöppel, G., Lerch, M. M., Löhr, M., Notohara, K., Okazaki, K., Schneider, A., & Zhang, L. (2011). International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas, 40(3), 352-358. https://doi.org/10.1097/MPA.0b013e3182142fd2

Shrikhande, S. V., & Barreto, S. G. (2010). Extended pancreatic resections and lymphadenectomy: An appraisal of the current evidence. World J Gastrointest Surg, 2(2), 39-46. https://doi.org/10.4240/wjgs.v2.i2.39

Shrikhande, S. V., Barreto, S. G., Goel, M., & Arya, S. (2012). Multimodality imaging of pancreatic ductal adenocarcinoma: a review of the literature. HPB (Oxford), 14(10), 658-668. https://doi.org/10.1111/j.1477-2574.2012.00508.x

Shrikhande, S. V., Kleeff, J., Reiser, C., Weitz, J., Hinz, U., Esposito, I., Schmidt, J., Friess, H., & Buchler, M. W. (2007). Pancreatic resection for M1 pancreatic ductal adenocarcinoma. Ann Surg Oncol, 14(1), 118-127. https://doi.org/10.1245/s10434-006-9131-8

Shrikhande, S. V., Sivasanker, M., Vollmer, C. M., Friess, H., Besselink, M. G., Fingerhut, A., Yeo, C. J., Fernandez-delCastillo, C., Dervenis, C., Halloran, C., Gouma, D. J., Radenkovic, D., Asbun, H. J., Neoptolemos, J. P., Izbicki, J. R., Lillemoe, K. D., Conlon, K. C., Fernandez-Cruz, L., Montorsi, M., Bockhorn, M., Adham, M., Charnley, R., Carter, R., Hackert, T., Hartwig, W., Miao, Y., Sarr, M., Bassi, C., & Büchler, M. W. (2017). Pancreatic anastomosis after pancreatoduodenectomy: A position statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery, 161(5), 1221-1234. https://doi.org/10.1016/j.surg.2016.11.021

Shukla, P. J., Barreto, S. G., & Fingerhut, A. (2010). Do transanastomotic pancreatic ductal stents after pancreatic resections improve outcomes? Pancreas, 39(5), 561-566. https://doi.org/10.1097/MPA.0b013e3181c52aab

Sierzega, M., Popiela, T., Kulig, J., & Nowak, K. (2006). The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas, 33(3), 240-245. https://doi.org/10.1097/01.mpa.0000235306.96486.2a

Siriwardana, H. P., & Siriwardena, A. K. (2006). Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg, 93(6), 662-673. https://doi.org/10.1002/bjs.5368

SMFG. (2012). Genetik, S. F. f. M. (2012, 2012-11-23). "Utredning, uppföljning och omhändertagande av personer med misstänkt ärftlig ökad risk för tumörsjukdom - Pankreascancer."   Retrieved 2017-01-05, 2017. http://sfmg.se/download/riktlinjer/Cancergenetik/Hereditar_pankreascancer_SOTA_november_2012.pdf.

Smith, G. B., Prytherch, D. R., Meredith, P., Schmidt, P. E., & Featherstone, P. I. (2013). The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death. Resuscitation, 84(4), 465-470.

Smith, R. A., Bosonnet, L., Ghaneh, P., Raraty, M., Sutton, R., Campbell, F., & Neoptolemos, J. P. (2008). Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma. Dig Surg, 25(3), 226-232. https://doi.org/10.1159/000140961

Smoot, R. L., & Donohue, J. H. (2012). Modified Appleby procedure for resection of tumors of the pancreatic body and tail with celiac axis involvement. J Gastrointest Surg, 16(11), 2167-2169. https://doi.org/10.1007/s11605-012-1925-3

Socialstyrelsen. (2018). Nationella riktlinjer för prevention och behandling vid ohälsosamma levnadsvanor. : https://www.socialstyrelsen.se/regler-och-riktlinjer/nationella-riktlinjer/riktlinjer-och-utvarderingar/levnadsvanor/

Sosa, J. A., Bowman, H. M., Gordon, T. A., Bass, E. B., Yeo, C. J., Lillemoe, K. D., Pitt, H. A., Tielsch, J. M., & Cameron, J. L. (1998). Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg, 228(3), 429-438. http://www.ncbi.nlm.nih.gov/pubmed/9742926

Springett, G. M., & Hoffe, S. E. (2008). Borderline resectable pancreatic cancer: on the edge of survival. Cancer Control, 15(4), 295-307. http://www.ncbi.nlm.nih.gov/pubmed/18813197

Spångfors, M., Bunkenborg, G., Molt, M., & Samuelson, K. (2019). The National Early Warning Score predicts mortality in hospital ward patients with deviating vital signs: A retrospective medical record review study. Journal of clinical nursing, 28(7-8), 1216-1222.

Strasberg, S. M., Drebin, J. A., & Linehan, D. (2003). Radical antegrade modular pancreatosplenectomy. Surgery, 133(5), 521-527. https://doi.org/10.1067/msy.2003.146

Strasberg, S. M., & Fields, R. (2012). Left-sided pancreatic cancer: distal pancreatectomy and its variants: radical antegrade modular pancreatosplenectomy and distal pancreatectomy with celiac axis resection. Cancer J, 18(6), 562-570. https://doi.org/10.1097/PPO.0b013e31827596c5

Strasberg, S. M., Linehan, D. C., & Hawkins, W. G. (2007). Radical antegrade modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: ability to obtain negative tangential margins. J Am Coll Surg, 204(2), 244-249. https://doi.org/10.1016/j.jamcollsurg.2006.11.002

Strongman, H., Kausar, I., & Maher, T. M. (2018). Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK. Adv Ther, 35(5), 724-736. https://doi.org/10.1007/s12325-018-0693-1

Suker, M., Beumer, B. R., Sadot, E., Marthey, L., Faris, J. E., Mellon, E. A., El-Rayes, B. F., Wang-Gillam, A., Lacy, J., Hosein, P. J., Moorcraft, S. Y., Conroy, T., Hohla, F., Allen, P., Taieb, J., Hong, T. S., Shridhar, R., Chau, I., van Eijck, C. H., & Koerkamp, B. G. (2016). FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol, 17(6), 801-810. https://doi.org/10.1016/s1470-2045(16)00172-8

Sultana, A., Smith, C. T., Cunningham, D., Starling, N., Neoptolemos, J. P., & Ghaneh, P. (2007). Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. J Clin Oncol, 25(18), 2607-2615. https://doi.org/10.1200/JCO.2006.09.2551

Sundhedsstyrelsen. (2012). Pakkeforlöb for kraeft i bugspytkirtlen. In: Sygehusbehandling och beredskap Smssd, editor. 2012.

Takahashi, Y., & Suzuki, S. (2018). Preoperative pulmonary function testing and postoperative complications. J Thorac Dis, 10(Suppl 33), S3840-s3842. https://doi.org/10.21037/jtd.2018.09.37

Takaori, K., Bassi, C., Biankin, A., Brunner, T. B., Cataldo, I., Campbell, F., Cunningham, D., Falconi, M., Frampton, A. E., Furuse, J., Giovannini, M., Jackson, R., Nakamura, A., Nealon, W., Neoptolemos, J. P., Real, F. X., Scarpa, A., Sclafani, F., Windsor, J. A., Yamaguchi, K., Wolfgang, C., & Johnson, C. D. (2016). International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer. Pancreatology, 16(1), 14-27. https://doi.org/10.1016/j.pan.2015.10.013

Tanaka, M., Fernandez-Del Castillo, C., Kamisawa, T., Jang, J. Y., Levy, P., Ohtsuka, T., Salvia, R., Shimizu, Y., Tada, M., & Wolfgang, C. L. (2017). Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology, 17(5), 738-753. https://doi.org/10.1016/j.pan.2017.07.007

Tee, M. C., Krajewski, A. C., Groeschl, R. T., Farnell, M. B., Nagorney, D. M., Kendrick, M. L., Cleary, S. P., Smoot, R. L., Croome, K. P., & Truty, M. J. (2018). Indications and Perioperative Outcomes for Pancreatectomy with Arterial Resection. J Am Coll Surg, 227(2), 255-269. https://doi.org/10.1016/j.jamcollsurg.2018.05.001

Teshima, C. W., & Sandha, G. S. (2014). Endoscopic ultrasound in the diagnosis and treatment of pancreatic disease. World J Gastroenterol, 20(29), 9976-9989. https://doi.org/10.3748/wjg.v20.i29.9976

Tol, J. A., Eshuis, W. J., Besselink, M. G., van Gulik, T. M., Busch, O. R., & Gouma, D. J. (2015). Non-radical resection versus bypass procedure for pancreatic cancer - a consecutive series and systematic review. Eur J Surg Oncol, 41(2), 220-227. https://doi.org/10.1016/j.ejso.2014.11.041

Tol, J. A., Gouma, D. J., Bassi, C., Dervenis, C., Montorsi, M., Adham, M., Andren-Sandberg, A., Asbun, H. J., Bockhorn, M., Buchler, M. W., Conlon, K. C., Fernandez-Cruz, L., Fingerhut, A., Friess, H., Hartwig, W., Izbicki, J. R., Lillemoe, K. D., Milicevic, M. N., Neoptolemos, J. P., Shrikhande, S. V., Vollmer, C. M., Yeo, C. J., Charnley, R. M., & International Study Group on Pancreatic, S. (2014). Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery, 156(3), 591-600. https://doi.org/10.1016/j.surg.2014.06.016

Tonnesen, H., Nielsen, P. R., Lauritzen, J. B., & Moller, A. M. (2009). Smoking and alcohol intervention before surgery: evidence for best practice. Br J Anaesth, 102(3), 297-306. https://doi.org/10.1093/bja/aen401

Trottman, P., Swett, K., Shen, P., & Sirintrapun, J. (2014). Comparison of standard distal pancreatectomy and splenectomy with radical antegrade modular pancreatosplenectomy. Am Surg, 80(3), 295-300. http://www.ncbi.nlm.nih.gov/pubmed/24666872

Tseng, D. S., Molenaar, I. Q., Besselink, M. G., van Eijck, C. H., Borel Rinkes, I. H., & van Santvoort, H. C. (2016). Pancreatic Exocrine Insufficiency in Patients With Pancreatic or Periampullary Cancer: A Systematic Review. Pancreas, 45(3), 325-330. https://doi.org/10.1097/MPA.0000000000000473

Tseng, J. F., Pisters, P. W., Lee, J. E., Wang, H., Gomez, H. F., Sun, C. C., & Evans, D. B. (2007). The learning curve in pancreatic surgery. Surgery, 141(4), 456-463. https://doi.org/10.1016/j.surg.2006.09.013

Tseng, J. F., Raut, C. P., Lee, J. E., Pisters, P. W., Vauthey, J. N., Abdalla, E. K., Gomez, H. F., Sun, C. C., Crane, C. H., Wolff, R. A., & Evans, D. B. (2004). Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg, 8(8), 935-949; discussion 949-950. https://doi.org/10.1016/j.gassur.2004.09.046

Tsuboi, T., Sasaki, T., Serikawa, M., Ishii, Y., Mouri, T., Shimizu, A., Kurihara, K., Tatsukawa, Y., Miyaki, E., Kawamura, R., Tsushima, K., Murakami, Y., Uemura, K., & Chayama, K. (2016). Preoperative Biliary Drainage in Cases of Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Chemotherapy and Surgery. Gastroenterol Res Pract, 2016, 7968201. https://doi.org/10.1155/2016/7968201

Uesaka, K., Boku, N., Fukutomi, A., Okamura, Y., Konishi, M., Matsumoto, I., Kaneoka, Y., Shimizu, Y., Nakamori, S., Sakamoto, H., Morinaga, S., Kainuma, O., Imai, K., Sata, N., Hishinuma, S., Ojima, H., Yamaguchi, R., Hirano, S., Sudo, T., Ohashi, Y., & Group, J. S. (2016). Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet, 388(10041), 248-257. https://doi.org/10.1016/S0140-6736(16)30583-9

Wada, K., Takaori, K., & Traverso, L. W. (2015). Screening for Pancreatic Cancer. Surg Clin North Am, 95(5), 1041-1052. https://doi.org/10.1016/j.suc.2015.05.010

Valls, C., Andia, E., Sanchez, A., Fabregat, J., Pozuelo, O., Quintero, J. C., Serrano, T., Garcia-Borobia, F., & Jorba, R. (2002). Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. AJR Am J Roentgenol, 178(4), 821-826. https://doi.org/10.2214/ajr.178.4.1780821

Walter, D., van Boeckel, P. G., Groenen, M. J., Weusten, B. L., Witteman, B. J., Tan, G., Brink, M. A., Nicolai, J., Tan, A. C., Alderliesten, J., Venneman, N. G., Laleman, W., Jansen, J. M., Bodelier, A., Wolters, F. L., van der Waaij, L. A., Breumelhof, R., Peters, F. T., Scheffer, R. C., Leenders, M., Hirdes, M. M., Steyerberg, E. W., Vleggaar, F. P., & Siersema, P. D. (2015). Cost Efficacy of Metal Stents for Palliation of Extrahepatic Bile Duct Obstruction in a Randomized Controlled Trial. Gastroenterology, 149(1), 130-138. https://doi.org/10.1053/j.gastro.2015.03.012

Van den Broeck, A., Sergeant, G., Ectors, N., Van Steenbergen, W., Aerts, R., & Topal, B. (2009). Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol, 35(6), 600-604. https://doi.org/10.1016/j.ejso.2008.12.006

van der Gaag, N. A., Rauws, E. A., van Eijck, C. H., Bruno, M. J., van der Harst, E., Kubben, F. J., Gerritsen, J. J., Greve, J. W., Gerhards, M. F., de Hingh, I. H., Klinkenbijl, J. H., Nio, C. Y., de Castro, S. M., Busch, O. R., van Gulik, T. M., Bossuyt, P. M., & Gouma, D. J. (2010). Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med, 362(2), 129-137. https://doi.org/10.1056/NEJMoa0903230

van Halsema, E. E., Rauws, E. A., Fockens, P., & van Hooft, J. E. (2015). Self-expandable metal stents for malignant gastric outlet obstruction: A pooled analysis of prospective literature. World J Gastroenterol, 21(43), 12468-12481. https://doi.org/10.3748/wjg.v21.i43.12468

Van Heek, N. T., De Castro, S. M., van Eijck, C. H., van Geenen, R. C., Hesselink, E. J., Breslau, P. J., Tran, T. C., Kazemier, G., Visser, M. R., Busch, O. R., Obertop, H., & Gouma, D. J. (2003). The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg, 238(6), 894-902; discussion 902-895. https://doi.org/10.1097/01.sla.0000098617.21801.95

van Heek, N. T., Kuhlmann, K. F., Scholten, R. J., de Castro, S. M., Busch, O. R., van Gulik, T. M., Obertop, H., & Gouma, D. J. (2005). Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg, 242(6), 781-788, discussion 788-790. http://www.ncbi.nlm.nih.gov/pubmed/16327488

van Hilst, J., de Rooij, T., Klompmaker, S., Rawashdeh, M., Aleotti, F., Al-Sarireh, B., Alseidi, A., Ateeb, Z., Balzano, G., Berrevoet, F., Björnsson, B., Boggi, U., Busch, O. R., Butturini, G., Casadei, R., Del Chiaro, M., Chikhladze, S., Cipriani, F., van Dam, R., Damoli, I., van Dieren, S., Dokmak, S., Edwin, B., van Eijck, C., Fabre, J. M., Falconi, M., Farges, O., Fernández-Cruz, L., Forgione, A., Frigerio, I., Fuks, D., Gavazzi, F., Gayet, B., Giardino, A., Groot Koerkamp, B., Hackert, T., Hassenpflug, M., Kabir, I., Keck, T., Khatkov, I., Kusar, M., Lombardo, C., Marchegiani, G., Marshall, R., Menon, K. V., Montorsi, M., Orville, M., de Pastena, M., Pietrabissa, A., Poves, I., Primrose, J., Pugliese, R., Ricci, C., Roberts, K., Røsok, B., Sahakyan, M. A., Sánchez-Cabús, S., Sandström, P., Scovel, L., Solaini, L., Soonawalla, Z., Souche, F. R., Sutcliffe, R. P., Tiberio, G. A., Tomazic, A., Troisi, R., Wellner, U., White, S., Wittel, U. A., Zerbi, A., Bassi, C., Besselink, M. G., & Abu Hilal, M. (2019). Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched Study. Ann Surg, 269(1), 10-17. https://doi.org/10.1097/sla.0000000000002561

van Hooft, J. E., Uitdehaag, M. J., Bruno, M. J., Timmer, R., Siersema, P. D., Dijkgraaf, M. G., & Fockens, P. (2009). Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): a prospective multicenter study. Gastrointest Endosc, 69(6), 1059-1066. https://doi.org/10.1016/j.gie.2008.07.026

Wang-Gillam, A., Li, C. P., Bodoky, G., Dean, A., Shan, Y. S., Jameson, G., Macarulla, T., Lee, K. H., Cunningham, D., Blanc, J. F., Hubner, R. A., Chiu, C. F., Schwartsmann, G., Siveke, J. T., Braiteh, F., Moyo, V., Belanger, B., Dhindsa, N., Bayever, E., Von Hoff, D. D., Chen, L. T., & Group, N.-S. (2016). Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Lancet, 387(10018), 545-557. https://doi.org/10.1016/S0140-6736(15)00986-1

Wang, Q., Gurusamy, K. S., Lin, H., Xie, X., & Wang, C. (2008). Preoperative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev(3), CD005444. https://doi.org/10.1002/14651858.CD005444.pub2

Wang, Z., Chen, J. Q., Liu, J. L., Qin, X. G., & Huang, Y. (2013). FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis. World J Gastroenterol, 19(29), 4808-4817. https://doi.org/10.3748/wjg.v19.i29.4808

Varadhachary, G. R., Tamm, E. P., Abbruzzese, J. L., Xiong, H. Q., Crane, C. H., Wang, H., Lee, J. E., Pisters, P. W., Evans, D. B., & Wolff, R. A. (2006). Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol, 13(8), 1035-1046. https://doi.org/10.1245/ASO.2006.08.011

Warren, K. W., Christophi, C., Armendariz, R., & Basu, S. (1983). Current trends in the diagnosis and treatment of carcinoma of the pancreas. Am J Surg, 145(6), 813-818. http://www.ncbi.nlm.nih.gov/pubmed/6305226

Vasen, H., Ibrahim, I., Ponce, C. G., Slater, E. P., Matthai, E., Carrato, A., Earl, J., Robbers, K., van Mil, A. M., Potjer, T., Bonsing, B. A., de Vos Tot Nederveen Cappel, W. H., Bergman, W., Wasser, M., Morreau, H., Kloppel, G., Schicker, C., Steinkamp, M., Figiel, J., Esposito, I., Mocci, E., Vazquez-Sequeiros, E., Sanjuanbenito, A., Munoz-Beltran, M., Montans, J., Langer, P., Fendrich, V., & Bartsch, D. K. (2016). Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers. J Clin Oncol, 34(17), 2010-2019. https://doi.org/10.1200/JCO.2015.64.0730

Washington K, B. J., Branton P et al,. (2010). Protocol for the examination of specimens from patients with carcinoma of the exocrine pancreas. Northfield, IL: College of American Pathologists; 2010.

Watanabe, I., Sasaki, S., Konishi, M., Nakagohri, T., Inoue, K., Oda, T., & Kinoshita, T. (2004). Onset symptoms and tumor locations as prognostic factors of pancreatic cancer. Pancreas, 28(2), 160-165. http://www.ncbi.nlm.nih.gov/pubmed/15028948

Wellner, U. F., Krauss, T., Csanadi, A., Lapshyn, H., Bolm, L., Timme, S., Kulemann, B., Hoeppner, J., Kuesters, S., Seifert, G., Bausch, D., Schilling, O., Vashist, Y. K., Bruckner, T., Langer, M., Makowiec, F., Hopt, U. T., Werner, M., Keck, T., & Bronsert, P. (2016). Mesopancreatic Stromal Clearance Defines Curative Resection of Pancreatic Head Cancer and Can Be Predicted Preoperatively by Radiologic Parameters: A Retrospective Study. Medicine (Baltimore), 95(3), e2529. https://doi.org/10.1097/MD.0000000000002529

Wellner, U. F., Lapshyn, H., Bartsch, D. K., Mintziras, I., Hopt, U. T., Wittel, U., Kramling, H. J., Preissinger-Heinzel, H., Anthuber, M., Geissler, B., Koninger, J., Feilhauer, K., Hommann, M., Peter, L., Nussler, N. C., Klier, T., Mansmann, U., Keck, T., StuDo, Q. P. s. g., members of StuDo, Q., Pancreas registry of the German Society for, G., & Visceral, S. (2017). Laparoscopic versus open distal pancreatectomy-a propensity score-matched analysis from the German StuDoQ|Pancreas registry. Int J Colorectal Dis, 32(2), 273-280. https://doi.org/10.1007/s00384-016-2693-4

Wells, M., Macmillan, M., Raab, G., MacBride, S., Bell, N., MacKinnon, K., MacDougall, H., Samuel, L., & Munro, A. (2004). Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. Radiother Oncol, 73(2), 153-162. https://doi.org/10.1016/j.radonc.2004.07.032

Welsch, T., Borm, M., Degrate, L., Hinz, U., Buchler, M. W., & Wente, M. N. (2010). Evaluation of the International Study Group of Pancreatic Surgery definition of delayed gastric emptying after pancreatoduodenectomy in a high-volume centre. Br J Surg, 97(7), 1043-1050. https://doi.org/10.1002/bjs.7071

Wente, M. N., Bassi, C., Dervenis, C., Fingerhut, A., Gouma, D. J., Izbicki, J. R., Neoptolemos, J. P., Padbury, R. T., Sarr, M. G., Traverso, L. W., Yeo, C. J., & Buchler, M. W. (2007). Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery, 142(5), 761-768. https://doi.org/10.1016/j.surg.2007.05.005

Verbeke, C. S. (2008). Resection margins and R1 rates in pancreatic cancer--are we there yet? Histopathology, 52(7), 787-796. https://doi.org/10.1111/j.1365-2559.2007.02935.x

Verbeke, C. S. (2014). Resection margins in pancreatic cancer: are we entering a new era? HPB (Oxford), 16(1), 1-2. https://doi.org/10.1111/hpb.12122

Verbeke, C. S., Leitch, D., Menon, K. V., McMahon, M. J., Guillou, P. J., & Anthoney, A. (2006). Redefining the R1 resection in pancreatic cancer. Br J Surg, 93(10), 1232-1237. https://doi.org/10.1002/bjs.5397

Whitcomb, D. C., Gorry, M. C., Preston, R. A., Furey, W., Sossenheimer, M. J., Ulrich, C. D., Martin, S. P., Gates, L. K., Jr., Amann, S. T., Toskes, P. P., Liddle, R., McGrath, K., Uomo, G., Post, J. C., & Ehrlich, G. D. (1996). Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet, 14(2), 141-145. https://doi.org/10.1038/ng1096-141

WHO. (2019). WHO Classification of Tumours, 5th Edition, (Vol. 1).

Wigzell, K. (2009). En nationell cancerstrategi för framtiden. Report of the Commission of Inquiry on A National Cancer Strategy [SOU 2009: 11]. Swedish Government Inquiries, Government Offices of Sweden, Stockholm, Sweden.

Wijeysundera, D. N., Pearse, R. M., Shulman, M. A., Abbott, T. E., Torres, E., Croal, B. L., Granton, J. T., Thorpe, K. E., Grocott, M. P., Farrington, C., Myles, P. S., & Cuthbertson, B. H. (2016). Measurement of Exercise Tolerance before Surgery (METS) study: a protocol for an international multicentre prospective cohort study of cardiopulmonary exercise testing prior to major non-cardiac surgery. BMJ Open, 6(3), e010359. https://doi.org/10.1136/bmjopen-2015-010359

Wilentz RE SR, H. R. Screening of pancreatic cancer using techniques to detect altered gene products. In Pancreatic cancer, pathogenesis, diagnosis, and treatment. . Ed Reber HE, . Humana Press 1998:pp 113-36


Williamsson, C., Karlsson, N., Sturesson, C., Lindell, G., Andersson, R., & Tingstedt, B. (2015). Impact of a fast-track surgery programme for pancreaticoduodenectomy. Br J Surg, 102(9), 1133-1141. https://doi.org/10.1002/bjs.9856

Williamsson, C., Wennerblom, J., Tingstedt, B., & Jonsson, C. (2016). A wait-and-see strategy with subsequent self-expanding metal stent on demand is superior to prophylactic bypass surgery for unresectable periampullary cancer. HPB (Oxford), 18(1), 107-112. https://doi.org/10.1016/j.hpb.2015.08.009

Vincent, A., Herman, J., Schulick, R., Hruban, R. H., & Goggins, M. (2011). Pancreatic cancer. Lancet, 378(9791), 607-620. https://doi.org/10.1016/S0140-6736(10)62307-0

Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., Harris, M., Reni, M., Dowden, S., Laheru, D., Bahary, N., Ramanathan, R. K., Tabernero, J., Hidalgo, M., Goldstein, D., Van Cutsem, E., Wei, X., Iglesias, J., & Renschler, M. F. (2013). Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med, 369(18), 1691-1703. https://doi.org/10.1056/NEJMoa1304369

Wong, J. C., & Lu, D. S. (2008). Staging of pancreatic adenocarcinoma by imaging studies. Clin Gastroenterol Hepatol, 6(12), 1301-1308. https://doi.org/10.1016/j.cgh.2008.09.014

Vujasinovic, M., Dugic, A., Maisonneuve, P., Aljic, A., Berggren, R., Panic, N., Valente, R., Pozzi Mucelli, R., Waldthaler, A., Ghorbani, P., Kordes, M., Hagström, H., & Löhr, J. M. (2020). Risk of Developing Pancreatic Cancer in Patients with Chronic Pancreatitis. J Clin Med, 9(11). https://doi.org/10.3390/jcm9113720

Vujasinovic, M., Valente, R., Del Chiaro, M., Permert, J., & Löhr, J. M. (2017). Pancreatic Exocrine Insufficiency in Pancreatic Cancer. Nutrients, 9(3). https://doi.org/10.3390/nu9030183

Vårdhandboken. (2021). nutrition. https://www.vardhandboken.se/vard-och-behandling/nutrition.

Xiong, J. J., Tan, C. L., Szatmary, P., Huang, W., Ke, N. W., Hu, W. M., Nunes, Q. M., Sutton, R., & Liu, X. B. (2014). Meta-analysis of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Br J Surg, 101(10), 1196-1208. https://doi.org/10.1002/bjs.9553

Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., & Iacobuzio-Donahue, C. A. (2010). Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature, 467(7319), 1114-1117. https://doi.org/10.1038/nature09515

Yamada, S., Fujii, T., Hirakawa, A., Kanda, M., Sugimoto, H., & Kodera, Y. (2016). Lymph node ratio as parameter of regional lymph node involvement in pancreatic cancer. Langenbecks Arch Surg, 401(8), 1143-1152. https://doi.org/10.1007/s00423-016-1412-5

Yamada, S., Nakao, A., Fujii, T., Sugimoto, H., Kanazumi, N., Nomoto, S., Kodera, Y., & Takeda, S. (2009). Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery? Pancreas, 38(1), e13-17. https://doi.org/10.1097/MPA.0b013e3181889e2d

Yasuda, I., Iwashita, T., Doi, S., Nakashima, M., & Moriwaki, H. (2011). Role of EUS in the early detection of small pancreatic cancer. Dig Endosc, 23 Suppl 1, 22-25. https://doi.org/10.1111/j.1443-1661.2011.01113.x

Yekebas, E. F., Bogoevski, D., Cataldegirmen, G., Kunze, C., Marx, A., Vashist, Y. K., Schurr, P. G., Liebl, L., Thieltges, S., Gawad, K. A., Schneider, C., & Izbicki, J. R. (2008). En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg, 247(2), 300-309. https://doi.org/10.1097/SLA.0b013e31815aab22

Ying, L., Lin, X., Xie, Z. L., Hu, Y. P., Tang, K. F., & Shi, K. Q. (2013). Clinical utility of endoscopic ultrasound elastography for identification of malignant pancreatic masses: a meta-analysis. J Gastroenterol Hepatol, 28(9), 1434-1443. https://doi.org/10.1111/jgh.12292

Yoo, C., Hwang, J. Y., Kim, J. E., Kim, T. W., Lee, J. S., Park, D. H., Lee, S. S., Seo, D. W., Lee, S. K., Kim, M. H., Han, D. J., Kim, S. C., & Lee, J. L. (2009). A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer. Br J Cancer, 101(10), 1658-1663. https://doi.org/10.1038/sj.bjc.6605374

Yoshinaga, S., Suzuki, H., Oda, I., & Saito, Y. (2011). Role of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for diagnosis of solid pancreatic masses. Dig Endosc, 23 Suppl 1, 29-33. https://doi.org/10.1111/j.1443-1661.2011.01112.x

Zaky, A. M., Wolfgang, C. L., Weiss, M. J., Javed, A. A., Fishman, E. K., & Zaheer, A. (2017). Tumor-Vessel Relationships in Pancreatic Ductal Adenocarcinoma at Multidetector CT: Different Classification Systems and Their Influence on Treatment Planning. Radiographics, 37(1), 93-112. https://doi.org/10.1148/rg.2017160054

Zamboni, G., Luttges, J., Capelli, P., Frulloni, L., Cavallini, G., Pederzoli, P., Leins, A., Longnecker, D., & Kloppel, G. (2004). Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch, 445(6), 552-563. https://doi.org/10.1007/s00428-004-1140-z

Zhang, L., Sanagapalli, S., & Stoita, A. (2018). Challenges in diagnosis of pancreatic cancer. World J Gastroenterol, 24(19), 2047-2060. https://doi.org/10.3748/wjg.v24.i19.2047

Zhang, X. M., Mitchell, D. G., Dohke, M., Holland, G. A., & Parker, L. (2002). Pancreatic cysts: depiction on single-shot fast spin-echo MR images. Radiology, 223(2), 547-553. https://doi.org/10.1148/radiol.2232010815

Zhou, Y., Shi, B., Wu, L., & Si, X. (2017). A systematic review of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of the pancreas. HPB (Oxford), 19(1), 10-15. https://doi.org/10.1016/j.hpb.2016.07.014

Zhou, Y., Yu, J., Wu, L., & Li, B. (2015). Meta-analysis of pancreaticogastrostomy versus pancreaticojejunostomy on occurrences of postoperative pancreatic fistula after pancreaticoduodenectomy. Asian J Surg, 38(3), 155-160. https://doi.org/10.1016/j.asjsur.2015.02.002

Zhou, Y., Zhang, Z., Liu, Y., Li, B., & Xu, D. (2012). Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis. World J Surg, 36(4), 884-891. https://doi.org/10.1007/s00268-012-1461-z

Ziske, C., Schlie, C., Gorschluter, M., Glasmacher, A., Mey, U., Strehl, J., Sauerbruch, T., & Schmidt-Wolf, I. G. (2003). Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine. Br J Cancer, 89(8), 1413-1417. https://doi.org/10.1038/sj.bjc.6601263

Zorron Pu, L., de Moura, E. G., Bernardo, W. M., Baracat, F. I., Mendonca, E. Q., Kondo, A., Luz, G. O., Furuya Junior, C. K., & Artifon, E. L. (2015). Endoscopic stenting for inoperable malignant biliary obstruction: A systematic review and meta-analysis. World J Gastroenterol, 21(47), 13374-13385. https://doi.org/10.3748/wjg.v21.i47.13374

Åkerberg, D., Ansari, D., Bergenfeldt, M., Andersson, R., & Tingstedt, B. (2019). Early postoperative fluid retention is a strong predictor for complications after pancreatoduodenectomy. HPB.

Nästa kapitel
23 Vårdprogramgruppen